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Opt-out testing is a method for detecting disease in which patients are informed that 
they will be tested for a health condition unless they decline.  Opt-out testing for HIV has 
been advocated as a strategy to increase the number of people who know their HIV status, 
enabling earlier diagnosis and management.  This thesis presents the first documented 
exploration of opt-out HIV testing in Australia. 
A mixed-methods exploratory design was developed for this study.  The overarching 
conceptual framework was Implementation Science, the process of translating research 
evidence into clinical practice.  The research project commenced with an assessment of the 
need for a change in Australian HIV testing policy through a review of international and 
Australian evidence.  A systematic review of international qualitative research on opt-out 
HIV testing was then undertaken to synthesise existing evidence and develop new themes.  
Next, following institutional review board approvals, a qualitative study analysing health care 
providers’ beliefs about opt-out HIV testing was conducted.  Content analysis was used to 
develop themes from the interview data.  This analysis then informed the development of a 
theoretical framework to guide implementation and evaluation of an opt-out HIV testing 
program.  Finally, a prospective, mixed-methods trial was conducted to evaluate the effect of 
the opt-out approach on HIV testing rates in a primary health care service after the 
introduction of opt-out testing.  The observational part of the study compared HIV testing 
rates between usual practice (opt-in testing) and opt-out testing.  Finally, health care 
providers’ experiences with opt-out HIV testing were explored through interviews guided by 
the theoretical framework and cross-referenced with the findings on testing rates. 
The needs assessment identified a recent increase in HIV diagnoses in Australia, 
supporting a possible change in testing strategy.  Attitudes and Systems were the main themes 
arising from the systematic review of international health care providers’ beliefs about opt-
out HIV testing.  Attitudes captured health care providers’ beliefs about opt-out HIV testing, 
and Systems referred to the operational barriers and facilitators to the implementation of opt-
out HIV testing programs.  In the qualitative study, 23 physicians and nurse practitioners 
were interviewed about their views on opt-out HIV testing.  Health care providers’ beliefs 
about HIV testing were dichotomous: HIV testing should be treated as a “normal” practice 
(through the opt-out approach) or an “exceptional” practice (through risk factor-based 
testing).  Insights from this qualitative study led to the development of a comprehensive 
theoretical framework (integrating the Health Belief Model, Behavioural Economics, and 
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Normalisation Process Theory) for the implementation and evaluation of an opt-out HIV 
testing program.  In the trial of opt-out HIV testing, testing rates were similar between usual 
practice (315 tests per year) and opt-out HIV testing (344 tests per year), suggesting that few 
patients opted out.  In interviews following the trial, the participating health care providers 
found the opt-out approach to be acceptable. 
Health care services in Australia that have not considered opt-out HIV testing now 
have evidence that the approach may be easily implemented and acceptable to health care 
providers.  Attitudes and Systems affected acceptability and implementation of opt-out HIV 
testing in all phases of the research.  The theoretical framework developed for 
implementation and evaluation of the opt-out HIV testing trial can be used to guide 
development of other opt-out testing programs both locally and internationally.  Findings 
from this thesis form an initial evidence base for opt-out HIV testing in Australia that can 
underpin future clinical practice, research and policy. 
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Since the world first became aware of acquired immune deficiency syndrome (AIDS) 
in the early 1980s, HIV/AIDS has killed 35 million people worldwide (Joint United Nations 
Programme on HIV/AIDS (UNAIDS), 2016).  Life expectancy in many countries has 
decreased because of HIV (particularly in the developing world) because most deaths occur 
in people between the ages of 15 and 49, the prime childbearing years (Bloom, 2011).  Today 
there are 36.7 million people living with HIV, of whom only 17 million are on life-saving 
anti-retroviral medications.  In 2015, there were 2.1 million new HIV infections and 1.1 
million deaths from AIDS (UNAIDS, 2016). 
Although the story of the HIV epidemic is replete with tragedy and despair, it is also 
alive with human progress and hope.  Despite the grim statistics, the HIV epidemic has 
produced some of the greatest scientific achievements of the late 20th and early 21st centuries.  
Within just 30 years, scientists identified the virus, mapped its genome and phylogenetic 
origin, developed laboratory tests, ensured the safety of blood supplies, and developed 
numerous drugs to treat the infection (Gallo, 2002).  Scientific research has also fostered 
successful HIV prevention strategies such as male circumcision, condom use, and needle 
exchanges, which have averted millions of infections (Degenhardt et al., 2010; Madden & 
Wodak, 2014; Piot et al., 2015). 
In addition to the scientific progress spawned by the virus, HIV has advanced 
human rights.  Its disproportionate effect on the world’s poorest and most marginalised 
groups inspired activism on an unprecedented scale.  Across the globe, people refused to 
remain silent as their loved ones died (Killen, Harrington, & Fauci, 2012).  They fought 
against stigma and discrimination and pressured their governments to fund research, 
prevention, and treatment (Brandt, 2013).  Although HIV-related stigma and discrimination 
have diminished in some countries, they will remain present to some degree until HIV can 
be eradicated. 
Before effective anti-retroviral medications were available, HIV progressed to AIDS, 
which was always fatal.  HIV can be asymptomatic for a decade or more after infection.  
During this latent period, the virus can spread among sexual partners and drug-use networks 
long before illness appears.  The protracted latent period of HIV infection facilitated its 
spread from remote central Africa to the rest of the world in just a few decades (Sharp & 
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Hahn, 2011).  Identifying HIV infections by testing during this asymptomatic period is 
critical to individual health as well as the public’s health.  HIV treatment suppresses the 
virus, making it less likely to be transmitted to others. 
This thesis explores HIV testing in a primary health care service in Perth, Western 
Australia, which is just one facet of the vast, multi-dimensional, and ever-evolving story of 
HIV.  Australia is held in high regard across the globe for its success in averting a generalised 
epidemic through nonpartisan government initiatives such as needle syringe programs (Topp, 
Day, Iversen, Wand, & Maher, 2011).  Other nations have and will continue to look to 
Australia as a world leader in effective HIV policies and interventions. 
Background 
Australia has a low HIV prevalence compared to other countries.  Sustaining this low 
prevalence requires prompt identification and treatment of HIV infections.  HIV incidence in 
Australia has been rising steadily since 1999, and in 2014, an estimated 26% of HIV-infected 
individuals had immune deficiency (defined as a CD4 count below 350 cells per microliter) at 
the time of diagnosis (The Kirby Institute, 2014).  Australian data shows that the average 
interval between the time of HIV infection and diagnosis is 3.4 years, a significant period in 
which the virus could be transmitted to others (Australian Government Department of Health 
and Ageing, 2014).  Case reports from around Australia indicate that HIV infections are often 
unrecognised by health care providers until AIDS-defining illnesses occur (Bell, Waddell, & 
Chynoweth, 2013; Darbar & Coyle, 2011; Ma, Smith, & Gordon, 2015).  To decrease HIV 
transmission, the Australian Seventh National HIV Strategy recommends increasing HIV testing 
by 30% (Australian Government Department of Health and Ageing, 2014).  The research project 
in this thesis explores a new approach to HIV testing that could help to achieve this goal. 
Rationale for Opt-Out HIV Testing 
The importance of HIV testing was highlighted when effective HIV medications 
(combined anti-retroviral treatment or cART) became available in 1996.  These medications did 
not cure HIV, but they could suppress the virus to an undetectable level.  HIV-infected people 
with access to cART experienced a reduction in viral load and normalisation of their immune 
function (Gulick et al., 1997; Hammer et al., 1996).  People with HIV who thought they had a 
terminal illness now potentially had a full life ahead of them.  Due to ongoing improvements in 
cART, lifespan in people with HIV continues to increase.  A recent meta-analysis found that 
starting cART at age 20 added as much as 43.3 years to the lifespan (Teeraananchai, Kerr, 
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Amin, Ruxrungtham, & Law, 2016).  Studies have shown that people who are aware of their 
HIV-positive status tended to adopt safer sexual and drug use practices, which is crucial for 
public health (Mattson et al., 2014).  For individuals and the public to benefit from cART, HIV-
infected people must be identified through testing and connected to health services. 
Recent changes in cART recommendations make HIV testing even more urgent.  
Prior to 2014, only people with a certain level of immune deficiency (defined by CD4 count, 
a type of T-lymphocyte involved in immunity) were treated with cART.  In the START trial, 
which began in 2009, HIV-infected patients were randomised to either immediate cART 
initiation or deferred cART initiation (to be commenced after the CD4 count dropped below 
350 cells/cubic millimetres, which was usual practice at the time).  The START trial was 
conducted across 35 countries and included 109 Australian patients.  In 2015, the START 
trial was stopped when preliminary analysis showed that starting all HIV-infected people on 
cART reduced AIDS-related complications and deaths from AIDS (Lundgren et al., 2015). 
In 2015, based on US Department of Health and Human Services guidelines (Panel 
DHHS 2016) and emerging data from START and other randomised controlled trials 
(Grinsztejn et al., 2014; Temprano, 2015), the Australasian Society for HIV Medicine 
recommended that all HIV-positive people start cART regardless of their CD4 count 
(Australasian Society for HIV Medicine, 2017).  The Australian Government’s 
Pharmaceutical Benefits Scheme had removed its CD4 count requirement for HIV-positive 
people to obtain cART in 2014, making effective HIV treatment available from the time of 
diagnosis (Australian Government Department of Health, 2016).  With accessible and 
effective treatment available, it is imperative that people know their HIV status. 
Transition to the Opt-Out Approach to HIV Testing 
Throughout its history, the HIV epidemic has prompted innovations in clinical 
practice (e.g., the introduction of needle syringe programs and male circumcision) (Brandt, 
2013).  HIV testing processes are no exception.  In the early years of the HIV/AIDS epidemic 
(1981-2006), HIV testing in the US required separate patient consent and pre-test counselling 
(Centers for Disease Control and Prevention, 1993).  An HIV diagnosis was essentially a 
death sentence.  Pre-test counselling was intended to prepare patients for the dire 
consequences that could result from a positive test: social stigma, employment 
discrimination, mental health problems, viral transmission from mothers to their babies, and 
ineligibility for health or life insurance (Weiss & Their, 1988).  Pre-test counselling typically 
included education about the HIV infection and its usual course, how to minimise the risk of 
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being infected, and how the HIV test worked (important because early HIV tests were not as 
sensitive and took longer to process than current HIV tests) (Geren et al., 2014).  It also 
provided an opportunity to assess patients’ access to health care and other resources if they 
tested positive for HIV (Quinn, 1992). 
No one in the international HIV community disputed the fact that it was in patients’ 
and the public’s best interest to identify HIV infections.  But until the mid-2000s there was 
less agreement about the best strategy for HIV testing (Rhame & Maki, 1989).  Because of 
the stigma and discrimination associated with HIV, mandatory testing of the general 
population had previously been discouraged on moral and ethical grounds (Judd, Biggs, & 
Burrows, 1989; O’Brien, 1989).  As early as 1988, some doctors and scientists began to 
consider the individual and societal benefits of routine HIV testing in asymptomatic people 
(Rhame & Maki, 1989), although it would not become common practice for another 20 years. 
By the mid-2000s, there was abundant evidence from some countries that risk-factor-
based HIV testing was not identifying the extent of HIV infections (Goggin, Davidson, 
Cantril, O’Keefe, & Douglas, 2000; Lyons, Lindsell, Ledyard, Frame, & Trott, 2005; 
McDonald, Currie, & Bowden, 2006).  Late diagnosis and deaths from AIDS were still 
problematic (Liddicoat et al., 2004).  Pre-test counselling had not been shown to improve 
testing rates or health outcomes (Krauss et al., 2000; Robinson et al., 2002).  In 2006, the US 
Centers for Disease Control recommended an opt-out approach to facilitate HIV testing for 
the general adult population (Branson et al., 2006).  In opt-out testing, the HIV test is the 
default, meaning that patients are tested unless they explicitly refuse.  Since the opt-out 
approach requires more patient effort to decline than to accept, HIV testing rates were 
expected to increase.  (Opt-out testing should not be confused with mandatory testing; 
patients still test on a voluntary basis and provide informed consent).  Subsequent research 
supported the hypothesis that opt-out testing was less time-intensive than risk factor 
assessment and pre-test counselling, and was associated with increased rates of testing 
(Metsch, Feaster, Gooden, & et al., 2013). 
In opt-out HIV testing, pre-test counselling and risk factor assessment are omitted or 
deferred.  For health care providers who were trained to do these steps before conducting an 
HIV test, this was a major change in practice that required them to accept new ideas about the 
importance and effectiveness of pre-test counselling.  Now that cART had made HIV a 
manageable chronic disease, health care providers and patients were no longer faced with a 




In Australia, HIV testing has not evolved in tandem with treatment.  Pre-test 
counselling recommendations have not changed since the introduction of cART.  For 
example, a pre-test counselling checklist from the Western Australia Department of Health 
recommends informing the patient what HIV is, how HIV is transmitted, that if a positive test 
occurs, how it is treated, how antibody tests work, and the need to re-test after three months 
(Government of Western Australia Department of Health, 2012).  While this information is 
undoubtedly useful for patients, it also takes up precious time during the medical consult.  
There is no Australian evidence that pre-test counselling increases HIV testing rates or 
improves health outcomes.  (Conversely, there is no Australian evidence that pre-test 
counselling decreases testing or worsens health outcomes).  Studies from the US have shown 
that pre-test counselling does not decrease transmission of sexually transmitted infections.  
Pre-test counselling is costlier in terms of staff time and overhead than the more streamlined 
process of opt-out HIV testing (Metsch et al., 2013). 
Pregnant women are the only people in Australia who are recommended to have opt-
out HIV testing.  This recommendation was put forward in a guideline by the Royal 
Australian and New Zealand College of Obstetricians and Gynaecologists in 2006 (Royal 
Australian and New Zealand College of Obstetricians and Gynaecologists, 2015).  A review 
of scholarly and grey literature for this thesis found no evidence that this recommendation 
was informed by a literature review, needs assessment or feasibility study.  It was not 
supported by a formal implementation strategy or underlying theoretical framework.  Further, 
there was no evidence of monitoring or evaluation of opt-out HIV testing in pregnant women 
after the recommendation was made.  Although the lack of discussion about opt-out HIV 
testing for pregnant women may indicate that the practice may be feasible and acceptable to 
patients and health care providers in general, this cannot be assumed to be the case. 
For non-pregnant individuals, HIV testing in Australia is guided by the National HIV 
Testing Policy, which was last updated in 2013 (Australasian Society for HIV Medicine, 
2014).  The Australasian Society for HIV Medicine states that “a sexual, drug use and 
medical history should be conducted to assist in determining whether an HIV test should be 
conducted”.  Indications for HIV testing include clinical signs (such as an AIDS-defining 
illness or commonly co-occurring infections like tuberculosis), risk behaviours (specifically 
injecting drug use or unprotected sexual intercourse), health care worker exposure, and 
patient request for testing.  Whilst these guidelines are useful in relation to the decision to test 
for HIV or not, there is international evidence that risk factor-based testing is not effective in 
identifying some HIV infections.  Opt-out HIV testing would not detract from the need to test 
Introduction 
6 
in obvious situations such as an AIDS-defining illness or health worker exposure, but it 
would abbreviate the pre-test counselling, history-taking and risk factor assessment process 
advocated by current Australian recommendations.  Eliminating or truncating these 
established practices would represent a paradigm shift for Australian health care providers.  
This research project aimed to explore the acceptability and feasibility of this shift in a 
general practice in Western Australia. 
Research Objectives 
Objective 1: To describe health care providers’ perceived barriers, facilitators, beliefs, 
attitudes and self-efficacy in relation to opt-out HIV testing. 
Objective 2: To construct a health care providers’ health belief typology relating to 
HIV risk and testing in their client population. 
Objective 3: To explore evidence of acceptability by health care providers related to 
an opt-out HIV testing strategy, to inform a possible change in Australian practice. 
Objective 4: To design and trial an opt-out model of HIV testing in a primary health 
care setting, and examine health care providers’ perceptions of the change in practice. 
Objective 5: To determine if the pilot test increased HIV testing rates. 
Objective 6: To evaluate the acceptability and feasibility of opt-out HIV testing for 
health care providers. 
These objectives evolved over the course of the research project.  Initially, the second 
objective was to construct a typology of health care providers’ beliefs about opt-out HIV 
testing.  As the research progressed, the literature review expanded to include other theories 
and concepts.  Peer reviewers for the third publication (about Australian health care 
providers’ views on opt-out HIV testing) suggested an exploration of theories beyond the 
Health Belief Model.  Whilst health care providers’ beliefs were important, they did not 
address the behavioural and operational aspects of opt-out HIV testing.  It became clear that 
the opt-out HIV testing project in this thesis required a broader framework that explored the 
basis for and implications of, default-based interventions (Behavioural Economics [Rice, 
2013]) and operational implementation of the approach (Normalisation Process Theory [May 
et al., 2011]). 
Conceptual Framework for the Thesis 
The overarching conceptual framework for this thesis was implementation science, 
also known as knowledge translation or translational medicine.  Implementation science 
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examines the process of transforming research evidence into clinical practice (Braithwaite, 
Marks, & Taylor, 2014).  With this approach, diverse theories (such as Diffusion of 
Innovations or Normalisation Process Theory) and methodologies (with an emphasis on 
mixed-methods) are used to understand the gaps and bridges between science and clinical 
practice (Peters, Tran, & Adam, 2013). 
A common premise in implementation science is that health care providers and policy 
makers are reluctant to change clinical practice or policy according to scientific evidence 
(Greenhalgh & Wieringa, 2011).  The research objectives in this thesis did not presume that 
health care providers are inherently reluctant to adopt new practices.  Full awareness and 
integration of evidence are rarely achieved due to the complexity and decision-making 
burden of day-to-day clinical practice.  For example, health care providers may intend to 
follow a guideline, but because they see their patients as individuals with unique needs to 
whom the guideline may not fully apply, they continue their usual (non-evidence based) 
practice (Greenhalgh & Wieringa, 2011).  This research was designed to explore how health 
care providers’ beliefs and attitudes influence how they operationalise a change in practice. 
Implementation science can also inform the process of eradicating or doing away with 
practices that are not supported by evidence.  This thesis was developed around the idea that 
clinical practices (such as pre-test counselling) that do not lead to improved health outcomes 
or efficiency should be discontinued.  The final phase of the study explored health care 
providers’ views on HIV testing without pre-test counselling. 
One of the tenets of implementation science is that practice changes should not just 
happen without following a well-designed blueprint to guide implementation.  Effective 
translation of evidence to clinical practice requires involvement in: needs assessment, 
planning, feasibility or pilot studies, and ongoing evaluation (Hargreaves et al., 2016; van 
Bon-Martens, van de Goor, & van Oers, 2016).  From the start, this research set out to 
explore and develop an opt-out HIV testing intervention informed by a needs assessment, 
literature review, theoretical framework and implementation plan. 
Study Design 
This thesis is the culmination of a research project that aimed to explore opt-out HIV 
testing in Western Australia.  Although there was abundant research about opt-out HIV 
testing in other countries (Haukoos et al., 2011; O’Kelly, Byrne, Naughten, Bergin, & 
Williams, 2016; Yazdanpanah et al., 2010; Yazdanpanah et al., 2013), an initial scoping 
review of the scholarly and grey literature testing found limited research to inform opt-out 
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HIV testing projects in Australian health care settings. 
On this basis, an exploratory design was developed for this study.  Exploratory 
research is the initial step in a broader research project about an unknown or loosely-defined 
subject (Stebbins, 2001).  Unlike descriptive research, which simply counts, defines or 
measures objective phenomena, exploratory research generates themes that build theory or 
develop other research questions.  Exploratory research is often qualitative because there is 
insufficient knowledge of the phenomenon from which to design quantitative surveys or 
experiments.  When presented on its own, exploratory research cannot make inferences or 
generalisations and never draws final conclusions.  Instead, exploration of themes identifies 
potential associations between phenomena that can lead to further refinement of theories and 
hypotheses.  Exploratory research can also be used to identify outcomes (duToit, 2015).  In 
this thesis, exploratory research was used to explore particular outcomes (feasibility, 
acceptability and testing rates) of opt-out HIV testing on a small scale, laying the foundation 
for implementation into a larger population or a different setting. 
This exploratory research project is presented as a thesis by publication (Figure 1).  
The thesis began with integrative and systematic reviews of the literature on opt-out HIV 
testing to evaluate existing research on the topic in both international and Australian contexts 
(Chapter 2).  These reviews led to an initial exploration of Australian health care providers’ 
views on opt-out HIV testing through qualitative interviews.  The participants’ beliefs and 
attitudes about opt-out HIV testing were first analysed according to the Health Belief Model.  
As mentioned previously, subsequent in-depth analysis led to the conclusion that the Health 
Belief Model alone did not account for the breadth of themes about opt-out HIV testing that 
had emerged from the data (Chapter 3).  A comprehensive theoretical framework for 
implementation of opt-out HIV testing was then developed (Chapter 4).  This preliminary 
work formed the foundation for a trial of opt-out HIV testing in a general practice, which is 
the final study in this thesis (Chapter 5). 
In this final study, opt-out HIV testing was conducted by the health care providers at a 
general practice for a one-year period and compared to usual practice (in terms of the number 
of tests conducted in the previous year).  At the end of the intervention, the health care 
providers were interviewed about their experiences with opt-out HIV testing.  Research has 
shown that people describe their experiences through the prism of their beliefs and biases; 
qualitative findings alone do not describe an objective reality (Paley & Lilford, 2011).  In 
other words, it was important to compare the participants’ thoughts about opt-out HIV testing 
with the amount of testing they actually performed.  Quantitative data were collected to 
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describe an objective outcome (number of HIV tests with usual practice compared to the 
number of HIV tests with opt-out testing). 
The outcomes of the exploratory research were 1) an original implementation guide 
for opt-out HIV testing based on a tested theoretical framework; 2) an initial understanding of 
Australian health care providers’ views on opt-out HIV testing; and 3) a preliminary analysis 
of the feasibility and acceptability of opt-out HIV testing in a general practice.  Findings 
presented in this thesis provide evidence that can underpin future research and policy 
development. 
 
Figure 1.  PhD by Publication 
 
Needs assessment/literature review of the rationale for 
opt-out HIV testing in Australia. Published in 
Australasian Medical Journal
Systematic review of health care providers' views on 
opt-out HIV testing. Published in AIDS Care
Qualitative study of Australian health care providers' 
views on opt-out HIV testing. Published in BMC 
Public Health
Development of a theoretical foundation for the 
implementation of opt-out HIV testing. Published in 
Journal of Evaluation in Clinical Practice
Prospective mixed-methods study of opt-out HIV testing 
in a primary health care service in Western Australia. 





This chapter is comprised of two published literature reviews and a synopsis of the 
existing state of knowledge relating to opt-out HIV testing.  The first publication, Leidel, S., 
McConigley, R., Boldy, D., Girdler, S., & Wilson, S.  (2015).  Should Australia consider opt-
out HIV testing?  Australasian Medical Journal 8(1), 30-32.  
http://dx.doi.org/10.4066/AMJ.2015.2290, was essentially a needs assessment and discussion 
of the potential benefits of the approach.  Based on a scoping review of the international 
literature about opt-out HIV testing (current through the time of article submission, 
December 2014) the article provided a background for the present research.  Australian HIV 
data was presented, showing trends (such as an increasing rate of new HIV diagnoses among 
heterosexuals), supporting an exploration of opt-out HIV testing in Australia. 
The next section of this chapter is a second publication, Leidel, S., Wilson, S., 
McConigley, R., Boldy, D., & Girdler, S.  (2015); and Health-care providers’ experiences 
with opt-out HIV testing: a systematic review.  AIDS Care, 27(12), 1455-1467.  
http://dx.doi.org/10.1080/09540121.2015.1058895.  This article synthesised findings from a 
systematic review of health care providers’ views on opt-out HIV testing.  The studies 
meeting inclusion criteria were based on research from outside Australia, indicating there was 
a gap in knowledge about opt-out HIV testing in Australia. 
Following this publication, an additional literature review was undertaken of other 
studies about health care providers’ experiences with opt-out HIV testing (including 
Australian studies).  Because of the large number of articles on opt-out HIV testing published 
since “Should Australia consider opt-out HIV testing” and “Health care providers’ views on 
opt-out HIV testing” were published (January and July 2015, respectively), the additional 
review includes current articles through August 2016.  This final section expands on the 
published articles with an updated comprehensive analysis of key concepts of opt-out HIV 
testing (including consent, stigma, pre-test counselling, linkage to care, ethical challenges, 
cost, and efficiency).  Finally, gaps in knowledge about opt-out HIV testing in Australia that 
led to this research project are reviewed. 
Literature reviews 
11 



















































Rationale and aims for this integrative review 
Integrative literature reviews organise, synthesise and critique published research.  A 
variety of methodologies (e.g., case studies, original research, and theoretical articles) are 
analysed to form a new understanding of a phenomenon and are typically broader than other 
types of reviews, such as meta-analyses or systematic reviews (Whittemore & Knafl, 2005).  
This integrative literature review aimed to: 
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1. link the two literature review publications and the rest of the thesis through a 
critical discussion of the research underlying this thesis; and 
2. present the gaps in knowledge and unresolved issues about opt-out HIV testing in 
Australia, establishing the foundation for the final study in this thesis. 
By expanding on the evidence and concepts described in the published articles, this review 
provides an in-depth analysis of the current state of knowledge about opt-out HIV testing. 
Literature searches 
The objectives of the literature search were to compare Australian and international 
HIV testing practices, summarise the research on opt-out HIV testing to date, and identify the 
gaps in knowledge about opt-out testing in Australia.  The search strategy approach was 
adapted from PRISMA guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009).  See Figure 
2.  Literature searches were limited to publication dates ranging from 2006-2016.  The time 
frame was based on the year (2006) that the US Centers for Disease Control released its 
recommendation for opt-out HIV testing in the general population, forming the basis for 
many research articles on the topic.  Databases were selected for this search if they included 
concepts pertaining to HIV, such as medicine, nursing, and social sciences.  The search 
engines Ovid and ProQuest were used to search their respective databases.  Medline, Science 
Direct and CINAHL were searched between July and August 2016 (using the keywords 
detailed in Figure 1) to ensure relevant articles were discovered.  Due to the large volume of 
articles about HIV (1888), terms related to the basic science of HIV, treatment, vaccine 
development, and other types of testing were excluded.  Although they may have described 
interesting issues relevant to this thesis, articles about opt-out HIV testing in specific 
populations (such as pregnant women) were excluded because the present research aimed to 
evaluate opt-out HIV testing in a general adult population rather than specific groups.  Search 
terms were exploded to capture the varied terms for opt-out testing that appeared in the 
literature (such as “provider-initiated” or “non-targeted” testing).  Reference lists of the 
retained articles were hand searched to identify additional relevant articles, including high-
impact or highly cited articles (original research, theoretical papers, and commentaries) 
published before 2006.  Grey literature was identified from the retained articles’ reference 
lists and gathered by internet search engine.  Full-text review was conducted on the 
remaining 500 articles.  Following the full-text review, 71 articles about important concepts 
underlying opt-out HIV testing (such as classification error, consent, and pre-test counselling) 







Figure 2.  Literature search results, adapted from PRISMA (Moher et al., 2009) 
Research about other issues with opt-out HIV testing 
As previously noted, the first two publications for this thesis focused on the potential 
advantages of opt-out HIV testing in Australia.  To present a complete picture of the current 













Records identified after duplicates removed 
n=1888 
Articles retained after title and abstract review 
n=411 
Grey literature documents 
sourced from reference lists 
n=45 
Additional articles sourced 
from reference lists 
n=44 
Full text articles and grey literature documents reviewed 
n=500 
Articles selected based on 
subject areas considered to be 
essential to opt-out HIV testing  
n=58 
Grey literature selected based on 
subject areas considered to be 





























This section addresses common unexpected consequences and problems that have been 
described in the literature on opt-out HIV testing, such as classification errors, difficulties 
with consent and pre-test counselling, and stigma. 
Classification errors 
One risk of opt-out testing is known as an “error of classification”, first posited by Johnson 
and Goldstein (2003) in a seminal paper about opt-out organ donation (Johnson & Goldstein, 
2003) (p.1339).  The researchers found that defaults produced a robust benefit for organ donation 
(e.g., opt-out organ donation increased the number of donations compared to an opt-in approach).  
The authors cautioned that defaults could result in misclassification, where people are identified as 
organ donors against their wishes.  Conversely, the opposite misclassification occurs when people 
want to be donors, but if the situation arises, their organs are not donated. 
Classification error is pertinent to defaults in other health-related situations.  In the 
case of opt-out HIV testing, a classification error occurs if a patient who does not want to be 
tested is tested, or if a patient who wants to test is left out.  If misclassification occurs, people 
at highest risk of HIV may not test, limiting the health benefits of the opt-out approach.  
Conversely, people may accept opt-out HIV testing, realising later that they were not ready 
for testing at that time. 
Johnson and Goldstein’s (2003) findings in relation to organ donation may not apply 
to opt-out HIV testing.  Unlike HIV testing, organ donation benefits other people (organ 
recipients) directly, whereas the public benefits of opt-out HIV testing, such as potentially 
reducing transmission, may not be apparent for years.  Accordingly, the authors argued that 
defaults may not be as effective for interventions that create emotional responses.  Organ 
donation does not typically result in stigma or discrimination like HIV, with the latter 
possibly resulting in a greater emotional cost. 
One strength of Johnson and Goldstein’s study was its triangulation of experimental 
and observational data.  First, they performed an online experiment in relation to organ 
donation with opt-in, opt-out, and neutral conditions, demonstrating the impact of defaults 
on hypothetical decision-making.  Then they analysed observational data about organ 
donation rates in countries with opt-in versus opt-out approaches, which supported the 
experiment’s findings.  Although many subsequent studies across many clinical 
applications have built upon Johnson and Goldstein’s work, highlighting the risk of 
misclassification, this literature search did not find any studies about opt-out HIV testing 
that specifically tested for classification error.  However, several studies about HIV testing 
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have built upon Johnson and Goldstein’s work (Montoy, Dow & Kaplan, 2016; Zetola et 
al., 2008). 
Problems with consent 
Opt-out HIV testing omits separate written consent.  By signing the general consent 
for treatment, patients agree to HIV testing, but still need to understand what the testing 
process entails.  The CDC recommended that patients must be informed 1) that they are going 
to be tested, and 2) that they have the right to refuse testing (Branson et al., 2006).  Although 
removing separate written consent for HIV testing streamlines the testing process, verbal 
consent for the procedure is still required, a process comparable to other routine testing 
procedures.  For example, whilst a Pap smear would be covered by the general consent for 
treatment, providers would obtain verbal consent before doing a Pap smear.  Separate written 
consent may be valuable for health care providers because it provided evidence that the 
patient made an informed decision (potentially decreasing liability risk).  However, research 
showing increased liability for providers performing opt-out HIV testing was not identified. 
Historically, aiming to decrease stigma, AIDS activists took a patient-rights 
perspective on consent, elevating patient autonomy above all other considerations.  After 
effective HIV treatment became available, paediatricians were the first group to challenge 
consent procedures.  They argued that the process of separate consent and pre-test 
counselling was too onerous and would decrease HIV testing rates.  They believed that health 
care providers had an obligation to protect infants from HIV transmission during birth, and 
this overruled mothers’ right to decline to test (Bayer & Fairchild, 2006). 
Research found that eliminating separate written consent for HIV testing led to more 
testing, particularly among groups at highest risk for HIV.  An observational study 
conducted by the San Francisco Public Health Department found that eliminating separate 
consent increased testing rates and detection of HIV infections in homeless and uninsured 
men who tested infrequently (Zetola et al., 2008).  However, this study was conducted only 
a few months after the policy was implemented, as such it was unclear if the effect was 
sustained over time or if the study duration (12 months) was long enough to capture adverse 
events. 
Research suggests that even if the opt-out approach increased HIV testing rates, 
many researchers encountered problems with consent.  Several studies suggested that 
without separate written consent, opt-out HIV testing was not always voluntary.  A mixed-
methods study undertaken in Kenya found that patients often believed that they could not 
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refuse opt-out HIV testing (Njeru, Blystad, Shayo, Nyamongo, & Fylkesnes, 2011).  A 
strength of this study was its 93% survey response rate.  In a study from another African 
country, patients commonly believed that opt-out HIV testing was coercive; indeed, doctors 
admitted that they did not always inform patients that they were going to be tested (Evans & 
Ndirangu, 2011; Hardon et al., 2011).  A qualitative study of health care providers in a 
Spanish opt-out HIV testing program found that participants tested some patients for HIV 
without the patients’ knowledge (Navaza, Abarca, Bisoffi, Pool, & Roura, 2016).  However, 
the researchers reported that they did not reach data saturation, so other attitudes could have 
emerged.  There was no evidence from low-prevalence countries like Australia that patients 
were unknowingly tested for HIV, but these findings demonstrated that health care providers 
could overlook their obligation to gain patient consent before performing opt-out HIV 
testing. 
The power imbalance between health care providers and patients could also affect 
consent for opt-out HIV testing.  Some researchers suggested that patients thought they could 
not refuse testing because health care providers were in a position of authority (Celada, 
Merchant, Waxman, & Sherwin, 2011).  Bayer and Fairchild (2006) stated that opt-out HIV 
testing was “ram[ming] an HIV test down people’s throats without permission.”  (p.649) (Bayer 
& Fairchild, 2006).  Abhyankar (2014) suggested that opt-out testing uptake could be improved 
by giving patients more information about the risks and benefits of the options, and by 
emphasising their right to decline testing (Abhyankar, Summers, Velikova, & Bekker, 2014). 
Some studies found patient support for opt-out HIV testing without consent.  A survey 
of US prison inmates who had opt-out HIV testing found that patients often misunderstood 
the difference between opt-out and involuntary testing: over 40% thought that the testing was 
mandatory.  However, a majority (85%) of the inmates thought that HIV testing should be 
mandatory, although the World Health Organization opposes mandatory testing in any 
circumstance (World Health Organization, 2012).  A drawback of this study was that 
researchers did not control for the variation in the way nurses offered the test (e.g., some 
nurses were observed to use active choice language such as “would you like an HIV test?”  
instead of opt-out) possibly influencing prisoners’ beliefs about whether testing was 
voluntary.  The survey results alone did not provide an explanation for these beliefs.  
Qualitative interviews exploring attitudes and beliefs about consent might have enriched the 
findings.  Nonetheless, this study provided more evidence that health care providers may 
need to explain the fundamental difference between opt-out testing and mandatory testing 
(Rosen et al., 2015). 
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A similar issue that surfaced in the literature was patients’ mistaken assumption that 
they were tested for HIV during a health encounter.  A British study found that 38% of 
surgical patients thought they had been tested for HIV during their preoperative evaluation 
when in fact they had not.  The patients did not receive any test results from the evaluation, 
yet 93% assumed they had a negative HIV test.  If people assume they do not HIV, they may 
forgo further testing or continue high risk behaviours, potentially leading to more HIV 
transmission (Albrecht et al., 2012).  A noted limitation of this study is that the questionnaire 
did not ask the participants why they thought they were tested for HIV.  The idea that health 
care providers needed to inform their patients when HIV tests were not performed was unique 
among the articles in this review. 
Consent in special situations 
Most research on opt-out HIV testing was conducted in primary care, jails, or 
emergency settings.  Few studies investigated opt-out HIV testing when the patient was not 
competent to make health care decisions.  The CDC guidelines did not describe opt-out HIV 
testing for patients who were intoxicated, unresponsive, unable to speak or understand the 
dominant language, or gravely ill. 
The exclusion criteria varied across the opt-out HIV testing programs included in this 
review, limiting the ability to generalize from their findings.  Several studies from emergency 
departments did not state if incapacitated patients were excluded from opt-out HIV testing due 
to their inability to give consent (Arbelaez et al., 2009).  In some studies, only patients arriving 
through triage were tested, perhaps based on an assumption that patients arriving by 
ambulance could not provide consent (though this was not explicitly stated) (Brown, Shesser, 
& Simon, 2007).  Other researchers reported that extremely unwell patients were excluded 
because they could not give informed consent (Haukoos et al., 2009; Sattin, Wilde, Freeman, 
Miller, & Dias, 2011).  A jail-based opt-out HIV testing program excluded inmates with active 
suicidal ideation, but did not mention other common symptoms (such as hallucinations) that 
would make consent difficult to obtain (Kavasery et al., 2009).  One US study suggested that 
excluding mentally ill people from opt-out HIV testing represented a missed opportunity.  
After changing laws to allow opt-out testing in inpatient psychiatric facilities, HIV testing 
increased by 60% from previous years in one facility (Weller, Levitt, Myers, Riley, & 
Gesmundo, 2016).  It was not clear if other psychiatric facilities showed a similar increase. 
A qualitative study of opt-out HIV testing in a critical care unit found that providers 
and families were frustrated when HIV testing was clinically indicated but consent could not 
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be obtained.  Interviews and focus groups were conducted among discharged critical care 
patients, family members, and health care providers, providing a range of perspectives.  
Participants suggested that specific guidelines for HIV testing in critical care should be 
developed (Martin et al., 2015).  This study was conducted in South Africa, a high HIV 
prevalence country, so it may not be transferable to other settings.  An ethical analysis 
concluded that if possible, competency to make decisions should be assessed before opt-out 
testing occurs (Hanssens, 2007).  Some researchers recommended that when a patient was 
under sedation or on mechanical ventilation, opt-out HIV testing should be performed with 
consent from a family member or health care proxy.  Opt-out HIV testing by proxy was not 
addressed in the literature, but could be beneficial in critical care settings, where knowledge 
of HIV status is paramount (Blackwell & Guido-Sanz, 2016). 
Another theme in the reviewed literature related to opt-out HIV testing among 
migrants.  In migrant health services, there is a power imbalance and unequal knowledge 
between provider and patient (influenced by culture and language) that could complicate the 
issues around consent for opt-out HIV testing.  A study from Belgium found that GPs were 
less likely to perform opt-out HIV testing on migrants due to ethical concerns, reasoning that 
migrants might not have access to care if they tested positive for HIV (Manirankunda, Loos, 
Debackaere, & Nostlinger, 2012).  Although Australia’s Seventh National HIV Strategy 
2014-2017 designated migrants as a priority population for HIV prevention and education, 
there was a lack of evidence about how to meet their needs (Australian Government 
Department of Health and Ageing, 2014).  A systematic review of HIV testing of migrants in 
high income countries did not find any Australian research on the issue (Alvarez del Arco et 
al., 2013).  People with HIV are generally not eligible to migrate to Australia, and all 
migrants aged 15 or older who are applying for permanent visas are required to be tested for 
HIV (although refugees and other humanitarian entrants may qualify for a health waiver) 
(Australian Government Department of Immigration and Border Protection, 2016). 
Another unsettled issue pertinent to all countries is whether victims of sexual assault 
should have opt-out HIV testing.  No studies addressing this scenario were found in the 
literature searches.  It is not known if patients or health care providers would find the opt-out 
approach to be acceptable in post-sexual assault clinical encounters.  Extra caution may be 
required to ensure that HIV testing would not be coercive.  If opt-out HIV testing is 
implemented in Australia, special consideration should be given to this situation. 
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Stigma and discrimination, domestic violence 
Researchers posited that the risk of stigma and discrimination from HIV testing may 
be diminished with the opt-out approach (Abdool Karim, 2011; White et al., 2015; Wynia, 
2006).  Many studies reported that HIV stigma is prevalent.  For example, numerous studies 
reported that women with HIV had an increased risk of being a victim of intimate partner 
violence, though these studies were conducted in the US or sub-Saharan African countries 
and may not apply to Australia (Durevall & Lindskog, 2015; Hatcher et al., 2016; Njie-Carr, 
2014).  A US study of HIV-positive people found that 73% had experienced intimate partner 
violence, and 29% believed that the violence was provoked by their HIV status 
(Ramachandran, Yonas, Silvestre, & Burke, 2010).  However, it must be considered that this 
was a small pilot study in an urban setting and may not apply to larger segments of the 
population or to rural areas. 
Research identified an association between intimate partner violence and HIV.  An 
integrative review of HIV risk in abusive heterosexual relationships found that the male often 
refused to use a condom and the woman was unable or afraid to persuade him to do so 
(Phillips et al., 2014).  The study did not identify causality or temporal relationships between 
intimate partner violence in HIV infection.  In a US survey that controlled for age, gender, 
and HIV risk behaviours, women with abusive partners were less likely to test for HIV even 
if at risk (Nasrullah, Oraka, Breiding, & Chavez, 2013). 
Numerous research studies have shown that HIV-infected people continue to 
experience discrimination (Chambers et al., 2015), including Australian people living with 
HIV (Slavin, 2012).  Even if most of their experiences with the health care system were 
positive, most HIV-positive people experienced episodes of discrimination, such as being 
asked by health care providers how they contracted HIV.  A study from the US showed that 
25% of HIV-infected patients thought their health care providers discriminated against them 
after learning of their status.  Although this study was conducted before opt-out HIV testing 
was recommended, the sample was nationally representative and could be generalised to the 
larger population (Schuster et al., 2005). 
In a study of HIV stigma in Quebec, researchers interviewed HIV-infected people 
about their interactions with health care providers.  The participants described behaviours that 
reflected health care providers’ stigmatised beliefs, like donning excessive personal protective 
equipment (such as face masks) to care for them (Gagnon, 2015).  A study of general practice 
patients in Britain found that opt-out HIV testing was acceptable, but patients feared they 
would be profiled based on their personal characteristics (such as sexual orientation).  Fear of 
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ostracism could lead to decreased testing rates, particularly among high risk groups that tend 
to be stigmatised.  Findings from this study were not definitive because the sample did not 
include men over age 25 who had sex with men, one of the main groups that the authors 
believed should undergo opt-out HIV testing (Glew, Pollard, Hughes, & Llewellyn, 2014). 
In a study that compared patients’ experiences with opt-in and opt-out testing, the 
authors hypothesised that because risk-based HIV testing commonly excluded heterosexuals 
or non-drug users, these groups were less likely to be tested.  The researchers found that most 
patients thought the routine offer of an HIV test was less stigmatising than having to ask to be 
tested.  On the other hand, some patients said that opt-out testing singled them out because of 
their personal characteristics (the opposite of what opt-out HIV testing intended to do).  But if 
the health care provider reassured patients by saying, “we are testing everyone”, they were 
more likely to accept testing.  Some patients even stated that their peers (who did not 
perceive themselves to be at risk for HIV) should have had opt-out testing.  One strength of 
this study was the relatively large number of interviews (50).  However, the participants were 
males aged 18-24, so it is unknown which approach would be acceptable to women or other 
age groups.  Although the sample was limited, making it difficult to generalise, this study 
demonstrated that the opt-out approach made HIV testing an unexceptional, non-stigmatising 
experience.  Moreover, it identified a simple statement that could be added to opt-out HIV 
testing programs (“we are testing everyone”) that decreased stigma and increased test 
acceptance (Knight, Small, & Shoveller, 2016). 
Some studies found that opt-in HIV testing was associated with stigma as well.  A US 
social psychology study gave participants a fabricated cover story about a stigmatised disease 
and then offered them hypothetical opt-in or opt-out testing.  The researchers found that the 
opt-in approach was associated with reluctance to test because participants feared their 
behaviours would be construed as immoral.  Opt-out approaches were associated with fear of 
ostracism or moral approbation for not testing (e.g.  if people were not willing to test, they 
were assumed to be HIV-positive).  The participants were more likely to test for the 
stigmatised disease if testing was offered as an opt-out rather than an opt-in.  While this 
experiment had limited external validity (it was conducted among healthy university students 
in San Francisco and used a fabricated, hypothetical case) it identified an association between 
opt-out approaches and peer influence (Young, Monin, & Owens, 2009). 
Whilst the previously mentioned studies indicated that opt-out HIV testing was less 
stigmatising than opt-in testing, other research found the opt-out approach did not decrease 
stigma.  A study of patients in a Los Angeles clinic explored the effect of the two 
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approaches on HIV-related stigma.  Immediately after they were offered HIV testing during 
a routine health care encounter, patients were asked if they were offered an HIV test and 
whether it was presented as an opt-in or opt-out.  The patients then completed a 
questionnaire regarding their beliefs about HIV and stigma.  The opt-out approach 
increased testing rates but did not decrease stigmatised beliefs as measured by the 
questionnaire (Mahajan et al., 2016).  A strength of this study was its high response rate 
(86%).  The researchers suggested that the health care providers should have offered more 
HIV education before testing to decrease stigma, although it would have been inconsistent 
with the concept of opt-out testing, which omits pre-test counselling.  Overall, the opt-out 
approach achieved its goal of increasing HIV testing rates.  Several studies found that opt-
out HIV testing decreased (or at least did not increase) stigma, but the study by Majahan 
(2016) highlighted the limitations of the opt-out approach in changing entrenched beliefs 
about HIV. 
Researchers reported that in areas where HIV was highly stigmatised, people often 
avoided health care services to protect their privacy.  In a survey of 1400 Nigerian men, a 
significant number agreed that attending health services signalled to the community that he 
was HIV-positive, leading to social distancing (Akanle, 2008; Celada et al., 2011).  A 
systematic review of stigma and HIV testing found that in some countries (especially in sub-
Saharan Africa) requesting an HIV test was an admission of promiscuity and therefore 
avoided (Mahajan et al., 2008). 
In a study conducted in Kenya and Uganda, researchers found that when both opt-in 
and opt-out HIV testing were available, couples tended to self-sort.  If one partner chose opt-
out testing, the other partner typically chose opt-in testing (Hardon et al., 2011).  A strength 
of this study was that it encompassed a variety of methods: direct observation, interviews 
with patients and health care providers, and focus groups of HIV-infected people.  Opt-out 
HIV testing could be the initial step in a sequence of testing strategies that are modified based 
on sexual networks, (e.g.  opt-out testing in the general population followed by targeted 
testing of the partners of HIV-infected people). 
Another finding from this study related to patients’ beliefs about local health services.  
Some patients made their decision to have HIV testing based on the quality of care they 
thought they would receive if they tested positive for HIV (Hardon et al., 2011).  Although 
this study was conducted in Kenya and was not generalizable to a well-resourced, low 
prevalence country like Australia, it raised an issue that the current Australian literature did 
not address: whether the expected quality of HIV care affected testing rates. 
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The weight of the evidence showed that opt-out HIV testing increased testing rates 
and sometimes (but not always) decreased stigma about the infection.  Regardless of testing 
strategy, HIV-related discrimination and violence remained problematic across a range of 
settings.  Some researchers suggested modifications to the opt-out approach (such as 
changing the wording of the opt-out offer) to address these issues. 
Pre-test counselling 
As previously discussed, opt-out HIV testing in the general population omits or 
abbreviates pre-test counselling.  Nonetheless, the 2006 CDC guidelines (Branson et al., 2006) 
were more nuanced than the first wave of research on opt-out HIV testing suggested.  The 
guidelines stated that “Patients found to have risk behaviors (e.g., MSM or heterosexuals who 
have multiple sex partners, persons who have received a recent diagnosis of an STD, persons 
who exchange sex for money or drugs, or persons who engage in substance abuse) and those 
who want assistance with changing behaviors should be provided with or referred to HIV risk-
reduction services (e.g., drug treatment, STD treatment, and prevention counselling).”  
(Branson et.al., 2006).  In other words, high-risk individuals could benefit from pre-test 
counselling, though this message was sometimes absent in studies about opt-out HIV testing. 
Although several Australian recommendations about pre-test counselling were 
identified for this integrated literature review (Australasian Society for HIV Medicine, 2014; 
Government of Western Australia Department of Health, 2012), there was no guidance about 
the amount of time required to perform adequate pre-test counselling or how to measure its 
quality.  Australian recommendations did not question the effect of pre-test counselling on 
health outcomes, efficiency or cost, although international evidence suggested minimal 
benefit. 
A US study randomised patients to pre-test counselling (including information about 
HIV and risk reduction advice) or no counselling, prior to HIV testing (Metsch et al., 2013).  
The researchers found that staff time, training, and quality assurance activities associated 
with pre-test counselling significantly increased costs.  Six months after the intervention, pre-
test counselling had not decreased the incidence of sexually transmitted infections, including 
HIV.  A strength of this study was its high retention rate (86.5%) between the intervention 
and follow-up testing (although incidence was only tested at six months, so it is not known 
how if the effect would last beyond that time frame).  A commentary on the same study 
suggested that health care providers did pre-test counselling primarily to feel like they were 
“doing something as opposed to nothing”, reflecting their tendency to continue ineffective or 
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inefficient practices (Haukoos & Thrun, 2013 p.1681), though the authors did not test this 
idea empirically. 
The limitations of pre-test counselling can also be viewed through a conceptual 
framework called the Health Impact Pyramid (Frieden, 2010).  Frieden posited that compared 
to improvements in the social determinants of health (such as better living standards or access 
to healthy food), counselling is the most time-intensive health intervention with the smallest 
benefit to the general population.  Counselling is not only the least effective modality for 
improving population health, it is also a barrier to positive health outcomes.  Smoking 
cessation is a prime example.  Only 10% of smokers quit in response to education; more 
people quit smoking because of “nudges” like smoke-free workplaces or tobacco taxes 
(Frieden, 2010). 
In the case of HIV, pre-test counselling historically included education about the use 
of condoms for prevention (Jones & Mitchell, 2014).  Like smoking cessation, research has 
shown that education about condoms was not as effective as changing the social norms to 
make condom use more common (Frieden, 2010).  An example of this principle was 
Australia’s success at achieving universal condom use among sex workers.  Advocacy and 
peer education (not education from individual health care providers) led to condom use 
becoming the norm rather than the exception (Bates & Berg, 2014).  Therefore, per the 
Health Impact Pyramid and its evidence base, pre-test counselling (which is resource-and 
time-intensive) could be reconsidered. 
In contrast, some research suggested that pre-test counselling may be required or 
desirable for patients in at least some instances.  A study of an opt-out HIV testing program 
in Spain found that some patients had erroneous information about HIV and HIV testing, 
suggesting that pre-test counselling might be helpful for people with low baseline knowledge 
about HIV (Navaza et al., 2016).  However, it must be considered that the sample for this 
study included only migrants to Spain from Latin America, so their knowledge base could 
have differed from Spaniards or other Europeans.  Pre-test counselling may have helped the 
migrants to understand HIV testing, possibly influencing their decision to test. 
Another study interviewed Belgian general practitioners about opt-out HIV testing 
among migrants from sub-Saharan Africa.  Participants stated that patients preferred the 
option to have pre-test counselling rather than have it skipped entirely (Manirankunda et al., 
2012).  A drawback of this study was that the migrants themselves were not interviewed.  
However, the general practitioners’ views indicated that opt-out HIV testing routine could 
accommodate different patient needs by offering pre-test counselling as an opt-in. 
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Pre-test counselling is typically done only when HIV testing occurs in clinical 
settings.  Home-based HIV testing kits are already available in some countries (Paltiel & 
Walensky, 2012).  One Australian company applied to the Therapeutic Goods Administration 
for approval of a home HIV test (Medew, 2016).  An Australian survey of gay men found 
that the majority would choose home-based HIV testing over testing in health services or at 
non-health venues such as nightclubs (Yang et al., 2014).  Preferences of the broader 
population are not known because the survey did not include heterosexuals or women, but 
home-based testing might appeal to a range of people.  Whilst some people may continue to 
seek HIV testing in health care settings, the findings from Yang (2014) (coupled with 
advances in testing) point to a diminishing role for pre-test counselling (Haukoos & Thrun, 
2013). 
Whilst Australian guidelines recommend pre-test counselling before HIV testing, 
evidence showed that the practice is costly and does not increase testing rates.  Counselling 
may be an ineffective strategy for improving population health outcomes.  Other research 
indicated the benefits of pre-test counselling for groups with less knowledge about HIV. 
Post-HIV test counselling 
Opt-out HIV testing can alter people’s responses to an HIV diagnosis.  Because opt-
out HIV testing is conducted as part of a routine health encounter that typically addresses 
other health issues, patients may not have considered the implications of the HIV test.  Some 
commentators suggested that patients who had opt-out HIV testing were more likely to be 
shocked by a HIV-positive diagnosis than if they had requested the test (Galletly, Pinkerton, 
& Petroll, 2008).  There was no consensus in the research as to whether opt-out HIV testing 
caused a different degree of emotional stress than opt-in testing. 
Some studies on opt-out HIV testing considered the ethical issues that could arise after 
a patient tested positive for HIV.  Researchers have identified examples of effective and 
ethical post-HIV test programs.  Hardon (2011) described a “supermarket” in Kampala, 
Uganda that housed many services for HIV positive people, including youth services, support 
groups, access to contraception and assistance with medications (Hardon et al., 2011).  Higher 
income countries also had examples of effective programs for HIV-positive people identified 
through opt-out testing programs (Parker et al., 2016; Tanner et al., 2016).   
Post-test counselling is a critical part of opt-out HIV testing programs.  Australian 
HIV organisations have broadly similar recommendations for post-test counselling that 
typically includes education about HIV laws and the patient’s responsibility to not transmit 
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the virus (Australasian Society for HIV Medicine, 2016).  In Australia, failure to disclose 
HIV-positive status can be considered a criminal act, and there have been numerous 
prosecutions (Cameron & Godwin, 2014).  However, a research-based best practice guideline 
for post-test counselling in opt-out HIV testing programs has not been tested or standardised. 
Failure to convey results and testing without linkage to care 
Testing for HIV without linkage to HIV care is considered unethical (World Health 
Organization, 2012).  In opt-out HIV testing, a subgroup of patients may not return for their 
HIV test result or may be lost to follow up, with consequences for the individual and public 
health.  Delay in linkage to HIV care or inadequate case management could result in legal 
problems for health services and health care providers.  Patients could theoretically bring a 
malpractice lawsuit because they were not informed they were being tested for HIV, did not 
consent, or did not fully understand the consequences before testing.  Opt-out HIV testing 
programmes should include a protocol for post-test counselling, linkage to care, and funding 
for both (Hanssens, 2007). 
A South African study explored differences in linkage to care between opt-in and opt-
out HIV testing.  At 12-month follow up, only two-thirds of the opt-out patients were linked 
to care, showing that the opt-out approach did not improve the time to CD4 testing (a marker 
of engagement with HIV care).  Poor linkage to care did not necessarily result directly from 
the opt-out approach because the participants were not randomised and the proportion of 
patients who returned for their results was not reported.  A low number of patients returning 
for results would have reduced the number of people who engaged in HIV care.  The authors 
suggested that opt-out HIV testing programs should develop a patient call back system to 
reduce the number of people who were lost to follow up (Leon et al., 2014).  An Australian 
commentary stated that linkage to care for HIV-positive people could be coercive, arguing 
that patients have the right to refuse treatment, though this argument was not supported by 
empirical evidence (Cameron & Godwin, 2014). 
Research commonly found that receipt of results and linkage to care for people with 
newly-diagnosed HIV was problematic (Christopoulos et al., 2011; Seth, Wang, Collins & 
Belcher, 2015).  One solution to the problem of poor follow-up was using rapid point-of-care 
HIV tests (which were approved in Australia in 2012) (Chan et al., 2015).  Funding was also 
a major determinant of follow up, although non-governmental funding in the US showed 
promise in improving linkage to care (Sanchez et al., 2014).  Numerous studies of opt-out 
HIV testing were conducted in US emergency departments (EDs) because they received CDC 
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funding to implement and evaluate the approach.  Funding typically allowed for case workers 
to coordinate receipt of test results and linkage to care (Haukoos et al., 2011).  Although 
these studies may not be relevant to Australian EDs because of variations in funding and 
referral systems, some barriers to ED-based HIV testing were common to both countries 
(such as limited resources and competing health priorities). 
Ethical issues 
Ethical issues surrounding opt-out HIV testing have generated research and 
commentary, although most articles on these topics were from outside Australia.  One study 
compared health care providers’ opinions on the ethics of opt-out testing (with general 
medical consent only and no pre-test counselling), with opt-in HIV testing (which required 
separate consent and pre-test counselling).  Health care providers preferred the opt-out testing 
method, but patients preferred the opt-in method.  These providers also found the 2006 CDC 
recommendations to be more ethically charged than traditional opt-in testing, but on balance, 
they thought opt-out HIV testing was reasonable to do.  It would be difficult to generalise 
from this study because it was conducted shortly after adopting the 2006 recommendations 
and the providers had little experience with the approach (Merchant et al., 2012). 
Cost of opt-out HIV testing 
Like all health interventions, opt-out HIV testing has an associated cost.  Some 
researchers found that because opt-out HIV testing increased testing rates, providers and 
administrators feared the approach would lead to over-testing and inefficiency (Celada et al., 
2011).  A study of opt-in versus opt-out testing from Washington DC (which had a high HIV 
prevalence of 2.4%) found that both methods were cost-effective at preventing HIV 
transmission, but opt-out testing was more effective at finding previously unidentified 
infections.  This study also found that opt-out HIV testing was costlier in terms of staff and 
resources, which contradicted findings from Metsch et al.  (2013) that the approach was less 
costly.  The authors point out that cost-effectiveness should not be the most important factor 
in HIV testing policies because the opt-out approach was superior at identifying HIV 
infections and averting transmission.  Linkage to care costs (such as social workers or case 
managers who facilitated referrals to HIV services) were another cost of opt-out HIV testing 
programs, but were not investigated in this study.  Although this study was from a high 
prevalence area not generalizable to Australia, it highlighted the balance required between 
cost-effectiveness and preventing HIV infections.  The study also suggested that a 
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combination of opt-out and opt-in HIV testing may result in the best cost-effectiveness and 
health outcomes (Castel et al., 2015). 
A cost-modelling study from Canada found that in higher prevalence settings, 80% of 
the HIV testing budget should be allocated to routine opt-out testing and 20% to targeted 
testing.  The study also found that opt-out HIV testing in lower prevalence settings (hospitals 
in this case) identified fewer HIV infections than opt-in testing.  Unlike other studies in this 
review, this study did not demonstrate a decrease in HIV risk behaviour after testing.  The 
model also assumed that all HIV-positive people were linked to care although this was not 
the case.  (Research has shown that about 90% of people newly diagnosed with HIV in 
Australia establish with HIV treatment services within three months, compared to only 40% 
in the US (Centers for Disease Control and Prevention, 2015; The Kirby Institute, 2014).  
Cost-effectiveness was best if opt-out HIV testing continued over 10 years, highlighting the 
need for continuous evaluation and monitoring of opt-out testing programs.  The authors 
recommended that health care providers modify HIV testing methods based on changing 
dynamics of the local epidemic (Kok et al., 2015). 
A cost-effectiveness study in the UK found that opt-out HIV testing was most cost-
effective in areas where the HIV prevalence was higher or where testing uptake was greater.  
Opt-out HIV testing took less time to administer than opt-in testing, resulting in cost savings 
(Ong et al., 2016).  However, this study measured HIV test uptake and its associated cost, not 
the HIV test offer rate, so it is not known what proportion of the patients opted out.  Test 
uptake between GPs and acute medical units was compared, but researchers did not control 
for provider-to-provider variation in testing rates within the groups.  Providers may have 
differed in their approach offering opt-out HIV testing. 
Another study of opt-out HIV testing in a London acute admissions ward found that it 
was cost-effective, but findings were based on testing uptake of only 75% (e.g., opt-out HIV 
testing may not have been cost-effective with 100% uptake).  This study ran for only 12 
weeks, so it was unclear if cost-effectiveness was sustained over time (Burns et al., 2013).  A 
similar US study found that opt-out HIV testing increased costs, but this was balanced with 
an increase in identification of HIV infections.  The US study was conducted at only one 
hospital, used only new HIV diagnoses as outcomes, and did not extrapolate the potential cost 
savings across the lifespan, such as quality-adjusted life years.  This study did not capture 
medical costs that were averted across the lifespan or the costs deferred because of decreased 
onward transmission (Haukoos et al., 2013).  After that study, the same authors developed a 
risk tool (based on two dimensions: men who have sex with men and injecting drug users) to 
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target high-risk individuals within the larger population that already had opt-out HIV testing.  
The risk tool identified more HIV infections compared to opt-out testing without a risk tool, 
increasing testing efficiency (Haukoos et al., 2013).  The authors suggested that after a period 
of opt-out testing in which a large group of people is tested, it may be appropriate to resume 
more targeted testing approaches (since the unidentified HIV diagnoses will have been 
discovered) (Haukoos, Hopkins, & Bucossi, 2014).  To date there were no Australian studies 
on the cost-effectiveness (or cost-benefit) of the opt-out approach to HIV testing. 
Differences between Australia and other countries 
Despite the benefits of opt-out HIV testing identified in the international literature, 
this evidence may not apply to Australia.  Indeed, a large portion of the research on opt-out 
HIV testing was done in the US because of funding for evaluation of the 2006 CDC 
recommendations.  Funding from the US also supported some of the research in African 
countries, which have markedly different HIV epidemics and resources from Australia 
(Alistar, Grant, & Bendavid, 2014; Reidy et al., 2016).  More recently, researchers from 
European countries such as Ireland, France, Belgium and Portugal investigated the opt-out 
approach, but it was unclear if their findings could be applied to Australia ((Hall et al., 2015; 
Manirankunda et al., 2012; O’Connell et al., 2016; The Kirby Institute, 2014; Yazdanpanah et 
al., 2010; Yazdanpanah et al., 2013). 
As noted previously with the linkage to care statistics, there are numerous differences 
between the HIV epidemics in the US and Australia.  For instance, Australia’s HIV epidemic 
is concentrated among urban gay men, whereas US cities such as Newark and Washington 
DC have generalised HIV epidemics primarily affecting heterosexuals (defined as a 
prevalence >1%) (Centers for Disease Control and Prevention, 2014).  The US has not 
adopted harm reduction strategies to the same degree as Australia, a world leader in HIV 
prevention.  Needle-syringe programs are less common in the US than Australia, and most 
US jurisdictions have not de-criminalised prostitution as Australia has done.  The two 
countries’ health care systems are essentially not comparable. 
Despite these differences, the large scale of the American studies on opt-out HIV 
testing made them worth examining.  The first major trial of opt-out HIV testing was in an 
emergency department in Denver; researchers used an opt-out approach to test over 28,000 
patients for HIV (out of 65,000 ED presentations during the two-year study period).  The 
researchers identified a modest number of HIV infections representing a prevalence of 
0.05%.  Opt-out testing was cost-effective, acceptable to patients and health care providers, 
Literature reviews 
46 
and did not cause workflow problems (Haukoos et al., 2010).  It may come as a surprise that 
Australia’s HIV prevalence (0.15%) is greater than the prevalence in the Denver study.  
Australia also has the same estimated percentage (14%) of undiagnosed HIV infections as the 
US (Centers for Disease Control and Prevention, 2015; The Kirby Institute, 2014).  While 
there are likely many differences between Australia and Denver, it is possible that opt-out 
HIV testing in Australia could have similar outcomes. 
Conclusion 
The literature review for this thesis commenced with a published scoping review of 
international literature about opt-out HIV testing.  This review found that the opt-out 
approach could lead to higher testing rates and earlier diagnosis of HIV.  Data showed that 
the incidence of HIV in Australia was increasing, particularly among heterosexuals, possibly 
due to increased travel to high prevalence areas.  More than half of new HIV infections 
among heterosexuals were diagnosed at later stages, suggesting that an exploration of opt-out 
HIV testing was needed.  The second part of the literature review was a systematic review 
also presented as a publication.  The systematic review synthesised qualitative findings to 
develop two themes that facilitated or impeded opt-out HIV testing: health care providers’ 
Attitudes and Systems. 
The integrative review then expanded on the literature reviews from the first and 
second publications, providing a broader context for the present research and addressing 
topics integral to opt-out HIV testing.  Research on opt-out HIV testing was analysed from a 
variety of perspectives, from consent in special situations to the economic costs of pre-test 
counselling.  Opt-out HIV testing has been implemented and evaluated in a wide range of 
settings around the world.  Research on the approach has been conducted using varied 
methodologies.  There was a paucity of research on opt-out HIV testing among the general 
adult population in Australia.  Although international evidence suggested many potential 
benefits of opt-out HIV testing, it was unknown if it would be feasible or acceptable to 
Australian health care providers.  This gap in knowledge led to the development of the 





The first objective of this research project was to describe health care providers’ 
perceived barriers, facilitators, beliefs, attitudes and self-efficacy in relation to opt-out HIV 
testing.  The literature reviews in the previous chapter aimed to synthesise research evidence 
about health care providers’ views on opt-out HIV testing.  Findings from this review formed 
an international context for the research project and laid the foundation for the next study in 
this thesis, an original qualitative research project about Australian health care providers’ 
views on opt-out HIV testing. 
The second objective was to construct health care providers’ health belief typology 
relating to HIV risk and testing in their client population.  The publication, Leidel, S., 
McConigley, R., Boldy, D., Wilson, S., & Girdler, S. (2015).  Australian health care 
providers’ views on opt-out HIV testing.  BMC Public Health, 15, 888.  doi:10.1186/s12889-
015-2229-9, is the first exploration of Australian health care providers’ beliefs about opt-out 
HIV testing.  Participants were asked to discuss their beliefs about opt-out HIV testing, 
revealing themes that went beyond health beliefs.  The theory of behavioural economics adds 
another dimension (testing by default) to the health belief typology. 
The methodological approach to this part of the research was qualitative, 
corresponding to the needs assessment part of the Implementation Science conceptual 
framework. A qualitative approach was chosen because Australian health care providers’ 
views on opt-out HIV testing had not been examined previously. Their views would offer an 
initial understanding of provider-sensitive issues that would need to be addressed in the 
implementation of an opt-out HIV testing program. 
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Theoretical analysis is further explored in the following publication, Leidel, S., Leslie, 
G., Boldy, D., & Girdler, S. (2016).  A comprehensive theoretical framework for the 
implementation and evaluation of opt-out HIV testing.  Journal of Evaluation in Clinical 
Practice, http://dx.doi.org/10.1111/jep.12602.  In this publication, three theories are 
combined to explore and synthesise aspects of opt-out HIV testing, from health care provider 
beliefs (the Health Belief Model) to the benefits of defaults in health care (Behavioural 
Economics), and finally to the operational processes required for implementation into 
practice (Normalisation Process Theory).  This theoretical framework in the following article 
was used as the coding scheme for the qualitative data in the final phase of this research. 
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Current HIV treatment guidelines recommend that all people with HIV take anti-
retroviral medications from the time of diagnosis to improve long term health outcomes 
(Australasian Society for HIV Medicine, 2017).  People diagnosed outside of a specialty HIV 
service should be referred immediately to an HIV treatment program to start these 
medications.  This process of connecting HIV-positive individuals to HIV treatment services 
is called linkage to care.  The World Health Organization defines linkage as: “the period 
beginning with HIV diagnosis and ending with enrolment in care or treatment” (World 
Health Organization, 2015)p.32).  The current international goal is for 90% of people newly 
diagnosed with HIV to be linked to care (UNAIDS, 2014). 
If HIV treatment services are limited, or treatment is available but patients do not 
establish care with HIV services, they do not benefit from early initiation of anti-retroviral 
medications.  Treatment services typically provide patient counselling about avoiding 
transmission to others, which has been shown to benefit public health.  Without established 
links to HIV treatment services, HIV testing programs confer no benefit to the patient’s or the 
public’s health (Branson et al., 2006; World Health Organization, 2015).  Due to the lack of 
benefit of testing without referral for antiretroviral medications, the World Health 
Organization recommends HIV testing only in areas where HIV treatment is available. 
Australia’s Seventh National HIV strategy also recommends that newly diagnosed 
patients with HIV are promptly referred for treatment (Australian Government Department of 
Health and Ageing, 2014).  Up to 50% of people living with HIV in Australia are not 
receiving HIV treatment because they were not connected to care or not retained in care 
(Wilson & Henderson, 2015).To increase the number of HIV-positive people who are 
engaged in treatment, barriers to care like access to specialty services, access to pharmacies 
that dispense antiretroviral medications, and lack of transportation should be addressed 
(Australian Government Department of Health and Ageing, 2014). 
Ethical issues 
The ethical basis for opt-out HIV testing includes confidentiality, informed consent, 
and linkage to care (Johnson, 2007).  In the final study in this thesis, health care providers at 
Homeless Healthcare adhered to their usual practices around confidentiality.  For example, 
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patients discussed HIV testing and had their blood drawn in a private exam room.  Only 
clinical staff with direct care responsibilities were present, and providers did not divulge any 
patient information to staff not involved with that patient or other patients.  Test results were 
not given over the phone or left on voice mail.  Patients were asked to return for a follow-up 
visit to discuss their results.  If a patient was found to be HIV-positive, the HIV treatment 
service was notified directly by health care providers not office staff.  Results were reported 
to the Health Department without patient-identifying information (Western Australia permits 
anonymous reporting of HIV). 
Health care providers who perform opt-out HIV testing have an ethical duty to obtain 
consent prior to testing, ensuring that patients are tested on a voluntary basis.  In the final 
study in this thesis, the participating health care providers obtained consent first with the 
general consent for medical treatment and then prior to performing opt-out HIV testing.  
Linkage to care is an additional ethical responsibility for providers who conduct opt-out HIV 
testing and is discussed below. 
Linkage to care in the present research 
The importance of linkage to HIV care as described above was integrated into the 
design of the final study in this thesis: a prospective, mixed-methods trial of opt-out HIV 
testing at Homeless Healthcare, a primary health care practice in Perth, Western Australia.  
This study aimed to determine if the opt-out approach affected HIV testing rates and explored 
its acceptability among health care providers.  It was possible that previously undiagnosed 
HIV infections might be discovered during the study period.  The study was designed with a 
mechanism for connecting newly diagnosed HIV-positive individuals with HIV specialty 
care.  Ethical issues around HIV testing were considered in the design of the trial because 
HIV infection is a stigmatized condition.  Over the past few years, researchers and clinicians 
have developed a model called the HIV care cascade (Kay, Batey, & Mugavero, 2016). 
In metropolitan Perth, HIV treatment services are delivered by the departments of 
clinical immunology at Royal Perth and Fremantle hospitals.  When a patient tests positive for 
HIV, the provider who ordered the test is notified of the result by the laboratory.  The provider 
then contacts the patient to discuss the results and refer him or her to one of the treatment clinics.  
In the present study, it was essential to ensure that this connection was formalized because opt-
out HIV testing program may uncover new diagnoses in people who are asymptomatic. 
The remaining research objectives relate to the trial of opt-out HIV testing at 
Homeless Healthcare, which is presented in this chapter as a publication: Leidel, S., Leslie, 
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G., Boldy, D., & Girdler, S. (2017).  “We didn’t have to dance around it:” opt-out HIV 
testing among homeless and marginalised patients.  Australian Journal of Primary Health.  
The objectives were to design and trial an opt-out model of HIV testing in a primary health 
care setting, examine health care providers’ perceptions of the change, and determine if the 
pilot test increased HIV testing rates.  Finally, the trial aimed to evaluate the acceptability and 
feasibility of opt-out HIV testing for health care providers. 
Reflexivity 
The author of this thesis was employed as a nurse practitioner at Homeless Healthcare 
before and during data collection and analysis. Her experience with opt-out HIV testing and 
in-depth knowledge of its related issues could have influenced her peers’ attitudes or testing 
practices.  To avoid introducing bias, the author was not a participant in the research and did 
not discuss opt-out HIV testing with participants during the study period. The number of HIV 
tests she conducted during the study period was not included in the data. 
Methodological approach and data analysis  
 The following study is a small-scale trial of opt-out HIV testing in a single health 
service, corresponding to the initial implementation phase of the Implementation Science 
conceptual framework. A mixed-methods design was chosen to interpret the opt-out HIV 
testing data together with the health care providers’ experiences. Combining the two data 
types would best inform development of a plan for wider implementation.  
This study took a novel approach to qualitative research by using a previously 
developed theoretical framework to conduct interviews and code and analyse the data. This 
process shared some characteristics with framework analysis, a qualitative method similar to 
grounded theory. Framework analysis is useful when the research aims to describe a specific 
group (like the health care providers at Homeless Healthcare), and typically leads to 
straightforward descriptions and interpretations of phenomena (Ritchie & Spencer, 1994). A 
more traditional approach to data analysis (e.g., grounded theory) could have identified 
different themes or generated a new theory. 
Ethics approval 
This final study was approved by the Human Research Ethics Committee of Curtin 
University.  Homeless Healthcare did not have an ethics committee, so the principal investigator 
presented the research proposal to a meeting that included the medical director and board of 
directors.  This group agreed to participate in the research and provided a letter of support. 
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Article 5. “We didn’t have to dance around it:” opt-out HIV testing among homeless 





















This thesis presents the first trial of opt-out HIV testing in Australia.  Opt-out HIV 
testing abbreviates the pre-test counselling, history-taking and risk factor assessment process 
advocated by current Australian HIV testing recommendations (Australasian Society of HIV 
Medicine, 2014).  The overall aim of this thesis was to inform a possible change in HIV 
testing practice by exploring health care providers’ views on opt-out HIV testing in a 
qualitative study, then by analysing their acceptance of the approach after implementing it in 
a primary health service.  The overarching framework was Implementation Science, the 
process of translating research evidence into clinical practice, including needs assessment, 
planning, feasibility studies, and ongoing evaluation (Hargreaves et al., 2016; van Bon-
Martens et al., 2016).  Although there were mixed opinions about opt-out HIV testing in the 
qualitative study, when implemented in a primary health care service, health care providers 
found it acceptable and identified few barriers. 
The research project began with the first step in Implementation Science processes: a 
needs assessment exploring the current state of HIV in Australia, identifying a recent increase 
in HIV diagnoses, particularly through heterosexual transmission.  This needs assessment 
article (Leidel et al.,2015, Australasian Medical Journal) analysed international evidence 
supporting opt-out HIV testing to identify undiagnosed infections.  Numerous studies 
suggested that opt-out HIV testing was effective at identifying HIV infections (Montoy et al., 
2012; Nayak, Welch & Kan, 2012) and was acceptable to health care providers (Bath et al., 
2015; Navaza et al., 2016; Simmons et al., 2011), although no Australian studies about the 
approach were identified. 
The next phase of the research was a systematic review (Leidel et al., 2015, AIDS 
Care) exploring international health care providers’ experiences with opt-out HIV testing, 
revealing two new themes: Attitudes and Systems.  Attitudes captured health care providers’ 
beliefs about opt-out HIV testing, and Systems referred to operational barriers and facilitators 
to the implementation of opt-out HIV testing programs.  These themes laid a foundation for 
the subsequent original research about opt-out HIV testing in Australia. 
Following these literature reviews, a qualitative study of Australian health care 
providers’ views on opt-out HIV testing was undertaken (Leidel et al., 2015, BMC Public 
Health).  About half the participants supported opt-out HIV testing, while the other half was 
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less accepting, citing a lack of Australian evidence supporting the approach.  Two contrasting 
themes emerged: Normalisation and Routinisation versus Exceptionalism, and Need for 
Proof versus Openness to New Approaches.  Qualitative analysis of the health care provider 
interviews was informed by the Health Belief Model (health care providers’ beliefs about 
HIV) and Behavioural Economics (the effect of default-based testing). 
Next, the Health Belief Model and Behavioural Economics were merged with 
Normalisation Process Theory (which addresses the operational factors related to opt-out 
HIV testing) to create a comprehensive theoretical framework.  These theories 
corresponded to the planning stage of the Implementation Science process.  Development 
of the framework was examined in a separate study (Leidel et al., 2016, Journal of 
Evaluation in Clinical Practice).  The framework guided qualitative data analysis in the 
final phase of the research. 
The culmination of the research and theoretical exploration was a prospective, mixed-
methods study of opt-out HIV testing in a primary health care service in Western Australia 
(Leidel et al., 2017, Australian Journal of Primary Health).  Consistent with the feasibility 
study and evaluation stages of the Implementation Science process, the effect of the opt-out 
approach on HIV testing rates was investigated over a 12-month period and compared to 
usual HIV testing practice in the previous year.  The opt-out approach did not affect testing 
rates, suggesting few patients opted out.  The participating health care providers were 
interviewed about their experiences with opt-out HIV testing, generally describing the 
approach as acceptable and feasible.  This final study provided initial evidence of the 
feasibility of opt-out HIV testing in an Australian setting which could inform opt-out HIV 
testing programs in other populations, or opt-out testing for other conditions. 
Review of the research objectives as they related to the findings 
The objectives of this research were addressed in a series of publications commencing 
with a needs assessment about opt-out HIV testing in Australia, progressed through literature 
reviews and theoretical analysis, and ended with the first Australian study of the approach in 
a primary health service.  It is worth noting that the objectives evolved in response to data 
analysis and peer review as the research progressed. 
The first three objectives of this research project explored health care providers’ 
beliefs and acceptance of opt-out HIV testing, with a goal of developing a typology that could 
inform implementation and evaluation of the practice.  Beliefs were associated with 
acceptance of opt-out HIV testing in the systematic review, the qualitative study, and the final 
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trial (e.g., health care providers with a positive attitude toward opt-out HIV testing accepted 
the practice, whereas providers who had less favourable attitudes did not accept it). 
The first paper (Leidel, et al., 2015, Australasian Medical Journal) identified 
potential benefits of opt-out HIV testing based on Australian HIV data and international 
experience with the approach.  Research from the US indicated that opt-in HIV testing was 
not effective at preventing late HIV diagnosis, leading to the recommendation for opt-out 
HIV testing (Branson et al., 2006).  Steady increases in HIV diagnoses in Australia since 
1999 coupled with an increase in heterosexual transmission suggested that a change in testing 
approach could be beneficial (The Kirby Institute, 2014).  With this context in mind, this 
research sought to explore opt-out HIV testing from an Australian context (which had not yet 
been studied) to inform a possible change in testing recommendations. 
The second paper (Leidel et al., 2015, AIDS Care) expanded on the first article with 
the first systematic review of qualitative research on international health care providers’ 
attitudes toward opt-out HIV testing.  Prior research focused on developing countries 
(Kennedy et al., 2013) or used quantitative or mixed-methods (Christopoulos et al., 2011; 
Glover Rucker et al., 2016; Harmon, Collins-Ogle, Bartlett, Thompson, & Barroso, 2014; 
Haukoos et al., 2010).  Qualitative research was a potentially rich source of health care 
providers’ beliefs and experiences that could not be fully explored with quantitative methods.  
A theme-driven evidence base about health care providers’ views on opt-out HIV testing was 
not yet well developed.  Themes from this systematic review would inform the subsequent 
study of health care providers’ views and the trial of opt-out HIV testing. 
Following this systematic literature search, the quality of the evidence was appraised 
and findings were synthesised, leading to the development of two overarching themes: 
Attitudes and Systems.  Health care providers’ decision making was influenced by their 
attitudes about opt-out HIV testing as opposed to empirically-based guidelines, affecting who 
was tested and in what circumstances.  System factors such as time, resources, and funding 
created barriers to opt-out HIV testing.  Insufficient time (or a perceived lack of time) was 
identified as a barrier in numerous studies on opt-out HIV testing (Arbelaez et al., 2012; 
Johnson, Mimiaga, Reisner, Van Derwarker, & Mayer, 2011; Mimiaga, Johnson, Reisner, 
Vanderwarker, & Mayer, 2011; Rizza, MacGowan, Purcell, Branson, & Temesgen, 2012).  
Research published after this review continued to identify lack of time as a major barrier to 
full implementation of opt-out HIV testing (Osorio et al., 2017).  Although time was a 
systems-related factor, it may have been related to attitudes (e.g., some health care providers 
did not see opt-out HIV testing as a priority in their practice, and therefore did not allocate 
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time to it).  Common facilitators of time management reported in other studies not covered by 
the systematic review were electronic reminders (Brennan et al., 2013; Marcelin et al., 2016; 
Schnall et al., 2014) and organisational support (Czagornski, 2013; Hood, Robertson & 
Baird-Thomas, 2015; Lo et al., 2013). 
The third paper, (Leidel et al., 2015, BMC Public Health) narrowed the focus from 
international health care providers to a group of primary health care providers in Western 
Australia; particularly Attitudes and Systems, which might influence the adoption of opt-out 
testing.  Before this study, Australian health care providers’ beliefs and attitudes toward opt-
out HIV testing were unknown.  Australia’s only experience with the opt-out approach was 
the 2006 guideline recommending opt-out HIV testing for pregnant women (Giles, Hellard, 
Lewin & Mijch, 2006; Royal Australian New Zealand College of Obstetrics & Gynaecology 
[RANZCOG], 2015), but no studies about Australian health care providers’ views on opt-out 
HIV testing for the antenatal population were found.  Although there was no evidence that the 
2006 RANZCOG guideline was controversial, it was clear there was a gap in knowledge 
about Australian health care providers’ attitudes toward opt-out HIV testing. 
The first contrasting theme that emerged from the study was Normalisation and 
Routinisation (treating HIV like other chronic diseases) versus Exceptionalism (treating HIV 
differently, for example requiring separate written consent for HIV testing).  This finding is 
comparable to previous research suggesting a dichotomy between HIV exceptionalism and 
the normalisation of opt-out HIV testing (Bayer & Fairchild, 2006; De Cock & Johnson, 
1998).  Most participants in this study favoured either Normalisation and Routinisation or 
Exceptionalism instead of more nuanced views (like normalising HIV testing in some settings 
and not others).  Participants in previous studies held similar views; in some cases, stating 
that Normalisation through the opt-out approach was a solution to the problem of HIV 
Exceptionalism (Smith & Whiteside, 2010).  Other participants concurred with researchers 
arguing that HIV should be treated differently because of its associated stigma (April, 2010; 
Evans & Ndirangu, 2009).  In the final study in this research project, participants cited 
normalisation as a benefit of the opt-out HIV testing program; their attitudes did not reflect 
HIV exceptionalism, suggesting that the experience of opt-out testing normalised HIV testing 
for health care providers. 
The second contrasting theme from the qualitative study was Openness to New 
Approaches versus Need for Proof.  Some participants were already taking an opt-out 
approach to HIV testing or were open to the idea.  Others identified barriers like an irrelevance 
to Australia, insufficient evidence in favour of the approach, and low perceived HIV risk in the 
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providers’ patient population, which have been reported in other studies (White & Walsh 
2015).  However, participants in prior research about opt-out HIV testing had not identified 
relevance to one country over another as a barrier.  As in the systematic review in this thesis, 
participants who were less accepting of opt-out HIV testing mentioned time as a barrier. 
Many participants had reservations about opt-out HIV testing because the evidence in 
favour of the practice was from international research.  However, some participants stated 
that if supporting evidence for opt-out HIV testing in Australian settings emerged, they would 
consider adopting the approach but did not suggest specific ways to gather this evidence.  
Participants in other studies of opt-out HIV testing did not suggest pilot tests either, which 
was a surprising finding because practice changes are often initially tested on a small-scale 
(Bath, Ahmad, & Orkin, 2015; Costello et al., 2013; O’Connell et al., 2016).  Given the 
weight of international evidence, using an Implementation Science framework, this pilot 
study could provide evidence before broader implementation was considered.  Participants’ 
comments about the lack of evidence supporting opt-out HIV testing highlighted the 
importance of starting an evidence base about the approach in Australia. 
In view of health care providers’ beliefs about evidence for opt-out HIV testing, the 
next step was to construct their health belief typology relating to the approach in their patient 
population.  The typology would be comprised of the categories of health care provider 
beliefs that emerged from the qualitative data and could inform subsequent research, theory 
development, and policy.  Other researchers have used theory to guide implementation of 
opt-out HIV testing (Kok, et al., 2015; Leon, 2014) but literature reviews for this thesis did 
not identify any research developed around an original typology or theoretical framework.  In 
order to address this, health care provider beliefs in the qualitative study were initially 
analysed per the Health Belief Model.  Next, the analysis expanded from beliefs to 
Behavioural Economics, the study of the effects of defaults (e.g., choices that are made 
automatically, unless an alternative is chosen) on decision making. 
As data analysis and peer review of the qualitative study progressed, it became clear 
that opt-out HIV testing was not affected solely by health care providers’ beliefs or by 
default-based decision making.  Therefore, the typology needed to expand beyond 
Behavioural Economics and the Health Belief Model to a broader theoretical framework.  
Operational factors (described by Normalisation Process Theory) also influenced the uptake 
of opt-out HIV testing.  Other studies of opt-out HIV testing have been guided by 
Normalisation Process Theory (Leon, Lewin, & Mathews, 2013).  A novel theoretical 
framework integrating Behavioural Economics, the Health Belief Model, and Normalisation 
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Process Theory was then developed and described in the fourth publication, (Leidel et al., 
2016, Journal of Evaluation in Clinical Practice).  The framework was used as a coding 
scheme for the qualitative data analysis in the final study verifying the utility of the 
framework, which presents a unique feature of this thesis that may be useful to other 
researchers and a key component of well-designed Implementation Science. 
Although the theoretical framework worked well for the research presented in this thesis, 
additional theories may have enriched the research design and data analysis.  For example, 
organisational change theory might have added the idea of a change agent or champion guiding 
the other participants to implement the new process (McCormack et al., 2013).  Organisational 
Change Theory and Normalisation Process Theory are similar because both theories pertain to 
collaboration among health care providers to implement practice changes.  Further, 
Organisational Change Theory could have built on individual beliefs from the Health Belief 
Model to explore the influence of organisational culture on the implementation of opt-out HIV 
testing.  For example, instead of focusing on individual opinions, participants could have been 
asked about opt-out HIV testing in relation to cultural norms within the organisation (Weiner, 
2009).  The stages of change concept from organisational change theory could have been used to 
analyse individual participants’ characteristics and their effect on implementation (Braithwaite et 
al., 2014).  For example, and as noted previously, the participants in the final study may have 
been Early Adopters, accounting for their mostly positive experiences with opt-out HIV testing 
(Sullivan, Ibrahim, Ellner, & Giesen, 2016).  The idea of Early Adopters was similar to the 
Openness to New Approaches theme identified in the qualitative study, though these themes 
contrasted with the health care providers who required supporting evidence for opt-out HIV 
testing before implementation. 
The final study further narrowed the research focus to a specific primary health care 
service in Western Australia, to determine if the opt-out approach increased HIV testing 
rates, and to evaluate its acceptability among health care providers.  After a 12-month trial of 
opt-out HIV testing, the participating health care providers were interviewed about their 
experiences.  Consistent with numerous studies from around the world, they reported high 
degrees of acceptability and self-efficacy with opt-out HIV testing, identified numerous 
facilitators to the program (like regular meetings and reminders), and reported few barriers 
(Kayigamba et al., 2014; Navaza et al., 2016). 
The providers’ acceptance of opt-out HIV testing in the final study contrasted with the 
less accepting participants in the previous qualitative study (Leidel et al 2015, BMC Public 
Health).  The participants in the trial of opt-out HIV testing (Leidel et al 2017, Australian 
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Journal of Primary Health) did not mention a need for evidence for the practice before 
implementation, suggesting they were more open to changing practice (Leidel et al., 2015, 
BMC Public Health).  This may reflect different individual attitudes and understanding (e.g., 
there were fewer early adopters in the qualitative study) or an organisational culture 
favouring new practices, or both.  Participants in the trial of opt-out HIV testing frequently 
mentioned the benefits of normalising HIV testing with the opt-out approach; unlike the 
previous study, views favouring HIV exceptionalism did not emerge. 
Part of the project was to design and trial an opt-out model of HIV testing in a 
primary health care setting (in this case Homeless Healthcare) and explore health care 
providers’ experiences with the change in practice.  Although linkage to care was a common 
concept in the HIV literature (Sanchez et al., 2014; Seth et al., 2015), a specific linkage to 
care protocol applicable to a Western Australian (or Australian) health service was not 
identified.  Therefore, a linkage to care protocol (Appendix 8) was developed during the 
design of the opt-out HIV testing project to be used in case of a positive HIV test during the 
study.  Development of the linkage to care protocol involving staff from the referring health 
service and the HIV Medicine service was an important feature of this research project not 
commonly discussed in the existing literature on opt-out HIV testing.  Ad hoc linkage to care 
was typically defined in terms of viral load or CD4 count, used different time frames for 
follow-up, and lacked a detailed description of the referral process (Coyle & Kwakwa, 2016; 
Hennessey et al., 2013; Leon et al., 2014).  The protocol for this study could be used to guide 
other researchers or health care providers considering an opt-out HIV testing program and 
could be applied to other health conditions requiring prompt specialty referral. 
The last study in this thesis, (Leidel et al., 2017, Australian Journal of Primary 
Health) was a prospective trial of opt-out HIV testing in a primary health care service.  
Compared to usual practice, opt-out HIV testing did not affect the number of HIV tests 
performed, a finding supported by previous research (Darling et al., 2012) but contrasting 
with other studies that found increased testing rates with the opt-out approach (Byamugisha 
et al., 2010).  Similar testing rates between opt-in and opt-out testing suggested (like 
numerous other studies) that few patients opted out (Hankin, Freiman, Copeland, & Shah, 
2014; Haukoos et al., 2013). 
The final intervention of this research project was implemented without major problems, 
making it difficult to analyse potential drawbacks of opt-out HIV testing.  In contrast to other 
studies of opt-out HIV testing (Galbraith et al., 2016), there were no adverse events during the 
intervention that required changes in the design of the trial.  Based on other researchers’ 
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experiences with opt-out HIV testing, it was expected that the opt-out HIV testing intervention 
would need to be modified during implementation (Christopoulos et al., 2011; Hennessey et al., 
2013).  For example, if the GPs did not have time to do opt-out testing, changes in practice may 
have been required, such as creating standing orders for nurses to do HIV testing (Davyduke, 
Pietersen, Lowrance, Amwaama, & Taegtmeyer, 2015; Evans et al., 2014).  Whilst the 
participants did not propose changes to the opt-out HIV testing process during this study, it has 
been reported elsewhere that staff have felt uncomfortable without adequate training when 
adopting this testing approach (Davyduke et al., 2015; Evans et al., 2014). 
Few barriers documented in other research, such as low provider self-efficacy, were 
encountered in this study (Akhter, Gorelick & Beckmann, 2012; Coeller, Kuo & Brown, 
2011).  The health care providers may have accepted opt-out HIV testing because it was easily 
implemented.  There was only one positive HIV test and no adverse events to interrupt their 
routine or increase their workload.  If there had been more positive HIV tests, the participants 
may have had different views.  For example, if staff resources and time were too scarce to 
manage post-test counselling, coordination of care, reporting to health authorities, and contact 
tracing, the providers’ experiences may have been less positive.  Adverse events like failing to 
link an HIV-positive patient to specialised care, which has been noted in previous research 
(Coyle & Kwakwa, 2016; Galbraith et al., 2016) could also have decreased acceptability.  
Conversely, because the health care providers agreed that opt-out HIV testing was acceptable, 
and there were few negative consequences, the approach could be acceptable if adopted more 
widely.  The possibility of identifying more HIV infections, and therefore improving patients’ 
and the public’s health, could be a motivator to continue opt-out HIV testing. 
Limitations 
The research presented in this thesis had several limitations.  One weakness was the 
homogeneity of the setting and participants.  The qualitative study was conducted in one 
Australian state with participants from mostly urban areas who may not have represented the 
full spectrum of beliefs and attitudes about opt-out HIV testing.  However, qualitative methods 
were appropriate because this was the first exploration of opt-out HIV testing in Australia and 
the themes, barriers, and facilitators were unknown (Greenhalgh et al., 2016).  The final 
prospective study of opt-out HIV testing took place in one health care organisation.  Although 
the same cohort of health care providers conducted the testing at all sites, seven different 
primary healthcare locations were represented in this study.  Further studies exploring opt-out 
HIV testing could expand to other health settings and include a larger sample of participants. 
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It is possible that the theoretical framework developed for this research would have 
been more robust with the inclusion of organisational change theory.  Organisational culture 
probably influenced the implementation of opt-out HIV testing, and this social dimension 
merited further exploration.  The theoretical framework has only been used for the small-
scale study in this thesis; it could be evaluated in different settings or in larger populations.  
Expanding exploration of the theoretical framework in other opt-out HIV testing programs 
could be part of the ongoing, post-intervention evaluation aspect of the Implementation 
Science process. 
Another limitation was that the research did not include patient views, which were 
commonly included in research about opt-out HIV testing (Cowan et al., 2013; Favre-Bulle et 
al., 2015, Schechter-Perkins et al., 2015) and could have enriched the analysis.  The literature 
review identified major concepts (like pre-test counselling, consent and stigma) which were 
explored from the health care providers’ perspectives.  The qualitative study of health care 
providers identified themes like Normalisation, but it is not known if patients thought the opt-
out approach normalised HIV testing.  Although the opt-out approach did not affect the 
number of HIV tests performed, Australian patient perceptions about opt-out HIV testing are 
unknown.  Prior research on opt-out HIV testing commonly found high levels of patient 
acceptance, typically defined as the number of tests completed compared to the number of 
tests offered (Mignano et al., 2016, Rucker et al., 2016; Rutstein et al., 2016).  In some cases, 
patients were more accepting of opt-out HIV testing than health care providers, who 
ironically appeared to be more concerned about privacy and consent than patients (White, 
Anderson, Pfeil, Graffman, & Trivedi, 2016). 
Future directions and impact 
This thesis presents an initial exploration of opt-out HIV testing that could guide 
further research and future implementation science guiding HIV testing practices.  A broader 
range of methodologies and theoretical perspectives would make the evidence base for HIV 
testing changes more robust.  For example, additional research could inform HIV testing 
policy development at local, state and federal levels of government.  Non-governmental 
professional organisations could refer to this evidence when writing new guidelines.  Selected 
issues that emerged from the literature reviews and original research are presented here as 




There was limited evidence on the effect of omitting pre-test counselling in the 
literature about HIV testing in Australia.  Now that home-based HIV testing is available, the 
consequences of testing without pre-test counselling need to be explored.  In the final study 
presented in this thesis, health care providers were in favour of leaving out pre-test 
counselling.  Attitudes about omitting pre-test counselling should be explored in more depth 
from both health care provider and patient perspectives.  Educational efforts to change health 
care provider behaviour (e.g., brief detailing sessions about the minimal effect of health 
education on behaviour) could be designed and tested.  Future studies could explore patients’ 
baseline knowledge about HIV prior to opt-out testing to explore potential associations 
between knowledge and acceptance of the opt-out approach. 
Avoiding classification errors 
Studies reviewed for this thesis identified potential classification errors with opt-out 
HIV testing: some patients did not know that the opt-out approach was voluntary, potentially 
leading to adverse events.  A positive HIV test in a person who did not know he or she was 
tested could lead to negative consequences.  Future research could also explore how health 
care providers should convey the message that patients are free to decline testing.  Another 
classification error identified in the literature review was patients’ belief that they were tested 
for HIV when they were not tested.  The causes of this belief and potential solutions could be 
explored.  Future research could be designed to control for classification errors. 
Special situations 
Opt-out HIV testing has not been explored in specific risk-related situations.  For 
example, the literature review conducted for this thesis found no studies on opt-out HIV 
testing in the setting of a sexual assault.  If victims present to health services for treatment 
after a sexual assault, they are typically offered pregnancy testing (for females) and testing 
for sexually transmitted infections, but there was no consensus on best practices for this 
situation.  Opt-out HIV testing may lead to increased testing and identify more HIV 
infections after assault but may be inappropriate for a person in an already vulnerable 
condition.  Sexual assault victims, advocates, and/or clinicians could be interviewed to 
explore the moral, legal and ethical issues with opt-out HIV testing in that situation. 
Another direction for future research could be opt-out HIV testing in the setting of 
accidental occupational exposure, a common trigger for HIV testing that was not studied in 
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the present research.  An opt-out approach could streamline this potentially stressful process, 
but omitting pre-test counselling could cause patient distress.  Studies investigating people’s 
preferences for pre-test counselling in this situation could guide practice.  The effect of opt-
out HIV testing on patient anxiety in stressful circumstances may merit further study. 
Opt-out HIV testing has not been studied in specific cultural or linguistic groups in 
Australia.  The patient population at the study site in this project was multicultural, but 
cultural and linguistic factors were not investigated.  Future research could investigate 
cultural and linguistic influences on the uptake of opt-out HIV testing.  For example, if 
members of a cultural group believe that health care providers are authority figures, they may 
be more likely to accept the HIV test, resulting in a classification error (in which people who 
do not want to be tested are tested). 
For the health care providers in previous studies as well as the present research, 
communicating with patients about opt-out testing was important (Walensky et al., 2011; 
Albrecht et al., 2012).  Health care providers should offer the HIV test as the default while 
still presenting the test as voluntary.  Participants in this research project did not always use 
the exact opt-out wording when offering the HIV test, as in some previous research (Montoy 
2016).  Patients whose first language is not English may not understand the subtle difference 
between opt-in and opt-out testing, potentially resulting in a classification error.  Interpreters 
(if they are available at the time of testing) may not convey the meaning of opt-out HIV 
testing adequately.  Before implementing opt-out HIV testing in a culturally or linguistically 
diverse group, these issues should be studied to identify best practices. 
The present research was conducted in a general practice setting in which the patients 
were typically competent to consent to treatment.  Previous research typically excluded 
patients who were not able to consent (Haukoos et al., 2012).  Little is known about opt-out 
HIV testing in situations in which patients cannot give consent and should be explored.  The 
literature review identified situations in which opt-out HIV testing has not been studied, such 
as severe mental illness, mechanical ventilation, or intoxication.  International evidence 
indicated that family members wanted to provide consent for severely ill patients (Martin et 
al., 2015), but this finding has not been replicated in other studies and has never been 
investigated in Australia. 
Research on consent in special situations could also include ethical implications of 
opt-out HIV testing.  In the qualitative study of Australian health care providers’ views on 
opt-out HIV testing, ethical issues did not emerge as themes, although other researchers and 
commentators had reported ethical concerns (Merchant & Waxman, 2012).  After the trial of 
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opt-out HIV testing in this study, health care providers were asked if they had any ethical 
concerns with the approach, but no concerns were expressed.  Future studies could explore 
these issues in different settings or with a larger sample. 
Opt-out HIV testing did not lead to higher testing rates in the final trial of this 
research project, possibly because the baseline prevalence in Australia was low.  To expand 
opt-out HIV testing, research in higher HIV-prevalence areas is needed.  Australia’s HIV 
epidemic is concentrated primarily among men who have sex with men (The Kirby Institute, 
2016).  Testing preferences in this population could be explored.  Some men who have sex 
with men may prefer home- or venue-based testing or testing in general practice.  Opt-out 
HIV testing could also be explored in sexual health settings with populations of men who 
have sex with men (who are at higher risk than the general adult population) (Yang et al., 
2014). 
Future research could also explore patients’ experiences after testing positive for HIV 
through opt-out testing.  The present research did not aim to examine this issue, but evidence 
suggests that HIV-related stigma remains a problem.  In future studies, patients could be 
interviewed about their experiences with stigma after opt-out HIV testing, possibly in 
comparison to stigma experienced after opt-in testing.  Patient experiences could inform 
future recommendations about post-test counselling and support.  There was no consensus in 
the research that opt-out HIV testing caused a different degree of emotional stress than opt-in 
testing, but it could be considered for future research. 
Cost-effectiveness of opt-out HIV testing needs to be studied in Australian health care 
settings.  Several participants in the qualitative study stated that opt-out HIV testing would be 
too expensive, suggesting that cost may influence health care providers’ decision to perform 
HIV testing.  Other participants believed that the cost of HIV tests was not a barrier.  
Numerous international studies of EDs, hospital wards and other settings have found opt-out 
HIV testing to be cost-effective (Farnham, 2008; Lucas & Armbruster, 2013).  Only one cost-
modelling study from Australia (which referred to antenatal opt-out HIV testing) was 
discovered (Graves, Walker, McDonald, Kaldor, & Ziegler, 2004).  Although this study 
found that opt-out HIV testing in antenatal settings was cost-effective, cost-effectiveness in 
Australian general practice is not known.  Further research could identify the most cost-
effective HIV testing practices for Australia. 
Conclusion 
The research in this thesis was guided by the Implementation Science process, 
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translating international evidence about opt-out HIV testing into an Australian setting for the 
first time.  Presented as a series of chapters and publications, the research was guided by the 
Implementation Science concepts of needs assessment, planning, feasibility studies, and 
evaluation.  Health care services that have not considered opt-out HIV testing now have 
evidence that the approach may be acceptable to health care providers and easily 
implemented.  Opt-out HIV testing programs would need to be tailored to each organisation; 
the novel theoretical framework created for this thesis could provide a starting point. 
The research identified the need for health care providers to be educated about the use 
of defaults in decision-making and preventing classification errors, but this education was not 
a barrier to the opt-out HIV testing program.  The Homeless Healthcare Linkage to Care 
Protocol developed for this study for HIV-positive patients could be adapted to different 
health services.  Using defaults (as per Behavioural Economics), the opt-out approach could 
be expanded to conditions that are more common than HIV, like depression, chlamydia or 
hepatitis C. 
This thesis is the first exploratory study of opt-out HIV testing in a primary health 
care service in Western Australia.  Literature reviews explored the previous research on opt-
out HIV testing outside of Australia, providing context for the approach.  Evidence about 
increasing HIV diagnoses in Australia offered a rationale for a possible change in HIV testing 
practice. 
Attitudes and Systems were the main themes arising from the systematic review and 
re-emerged in the findings and theoretical analysis.  Health care providers’ beliefs about 
HIV testing were dichotomous: HIV testing should be treated as a normal practice (with an 
opt-out approach) or an exceptional practice (through the usual method of risk factor-based 
testing).  Insights from this qualitative study led to the development of a comprehensive 
theoretical framework for opt-out HIV testing that was used in subsequent qualitative data 
analysis. 
These preliminary studies culminated in the final prospective study of opt-out HIV 
testing at Homeless Healthcare.  Health care providers found the opt-out approach to be 
feasible and acceptable, no adverse events occurred, and few patients opted out.  Findings 
from this thesis have established an initial evidence base to guide further development of opt-
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Appendix 1 Participant information sheet for the qualitative study (Leidel et al., BMC 
Public Health) 
 
Study title: An exploratory study of health care providers’ acceptance of opt-out HIV 
testing in Western Australia 
RESEARCH TEAM 
Ms Stacy Leidel, Lecturer & Nurse Practitioner, Curtin University School of Nursing and 
Midwifery 
Dr Ruth McConigley, Senior Lecturer, Curtin University School of Nursing and Midwifery 
Professor Duncan Boldy, Research Advisor, Curtin University School of Nursing and 
Midwifery 
Dr Sonya Girdler, Senior Lecturer, Curtin University School of Occupational Therapy and 
Social Work 
PROJECT INFORMATION 
What will I have to do? 
Our team would like to ask you about your views and practices related to HIV testing.  You 
may also be asked to nominate colleagues who would be interested in participating.  You will 
be asked to sign a consent form before the interview.  Participation is strictly voluntary and 
you are welcome to withdraw at any time during the research.  Being a participant will not 
have any negative consequences. 
The interview will be audio-recorded, transcribed, then analysed and written up as a 
report for publication.  The findings will be published in professional journals but will not 
contain any identifying information. 
Will I be paid to participate in the study? 
You will not be paid to participate in this study. 
Are there any risks involved? 
There are no risks involved with participation in this project. 
Appendices 
107 
What if I need more information? 
If you have any questions about the study please contact Stacy Leidel at 
stacy.leidel@curtin.edu.au 
Queries or complaints? 
This project has been approved by the Curtin University Human Research Ethics Committee, 
approval number SONM12-2014. 
If you wish to make a complaint on ethical grounds, please contact the Curtin 
University Human Research Ethics Committee (Secretary) by phone on 9266 2784 or by 
email to hrec@curtin.edu.au. 
Written complaints can be mailed to: C/- Office of Research and Development, Curtin 
University, GPO Box U1987, Perth WA 6845. 
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Ms Stacy Leidel, Nurse Practitioner, PhD Candidate, Curtin University School of Nursing 
and Midwifery 
Dr Ruth McConigley, Senior Lecturer, Curtin University School of Nursing and Midwifery 
Professor Duncan Boldy, Research Advisor, Curtin University School of Nursing and 
Midwifery 
Associate Professor Sonya Girdler, Curtin University School of Occupational Therapy and 
Social Work 
Dr Sally Wilson, Adjunct Faculty, Curtin University School of Nursing and Midwifery 
PROJECT INFORMATION 
What will I have to do? 
In this study we will ask you to implement opt-out HIV testing for all patients who are having 
pathology tests at Mobile GP clinics for a period of 12 months.  Opt-out HIV testing is when 
you tell the patient that you will perform the HIV test unless he or she declines.  Before we 
implement this change in practice, we will ask you to attend an educational session about this 
project at a regular staff meeting.  We would appreciate your input into the protocol 
development at this stage, but you are not required to be involved.  You will be asked to sign a 
consent form prior to participation.  We will not keep any identifying information about you. 
Once the protocol is developed, we will commence opt-out HIV testing.  You are not 
required to participate in this phase of the research and will experience no negative 
consequence for not participating.  If you choose to participate, you will perform an HIV test 
on all patients having routine blood tests unless they decline.  You would say something like 
this to your patients: “We are testing all patients for HIV if they are having pathology tests, is 
that all right with you?”  You would then proceed with pre-test counselling and informed 
consent as per your current HIV testing practice.  You or another staff member would then 
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draw the blood sample and send it to the laboratory according to the usual procedure for 
pathology tests.  Follow-up of test results and health department notification in case of a 
positive result would continue to be your responsibility. 
An adverse event protocol has been developed with input from the Department of 
Clinical Immunology at Royal Perth Hospital to assist you in the event of a positive HIV test.  
If this occurs, you will liaise with the RPH clinical nurse and social worker to ensure that the 
patient is connected to HIV services in a timely manner.  Our team is available to you should 
you have any concerns or require further support during the project. 
After the project period, our team would like to ask you about your experience with 
opt-out HIV testing.  We would also like to discuss things that facilitated or impeded this 
change in clinical practice.  You will be asked to sign a consent form before the interview.  
Participation is strictly voluntary and you are welcome to withdraw at any time during the 
research.  Being a participant will not have any negative consequences. 
The interview will be audio-recorded, transcribed, then analysed and written up as a 
report for publication.  The findings will be published in professional journals but will not 
contain any identifying information. 
Will I be paid to participate in the study? 
You will not be paid to participate in this study. 
Are there any risks involved? 
There are no risks involved with participation in this project. 
What if I need more information? 
If you have any questions about the study please contact Stacy Leidel at 
stacy.leidel@student.curtin.edu.au 
Queries or complaints? 
This study has been approved by the Curtin University Human Research Ethics Committee 
(Approval Number HR 4877).  The Committee is comprised of members of the public, 
academics, lawyers, doctors and pastoral carers.  If needed, verification of approval can be 
obtained either by writing to the Curtin University Human Research Ethics Committee, c/- 
Office of Research and Development, Curtin University, GPO Box U1987, Perth, 6845 or by 




Appendix 3 Consent form for participants for the qualitative study (Leidel et al., BMC 
Public Health) and the mixed-methods study (Leidel et al., Australian 
Journal of Primary Health) 
 
CONSENT FORM FOR PARTICIPANTS 
Study title: An exploratory study of opt-out HIV testing in Western Australia 
I have been given clear, written information about this research project and have been given 
time to consider whether or not I wish to take part. 
I understand and accept the nature of the project, which has been explained to my satisfaction. 
I understand that my interview will be audio-taped and transcribed. 
I know that my participation in this project is strictly voluntary.  I know that I have the right 
to withdraw at any time. 
If I have any questions about the project or about being a participant, I can call Stacy Leidel 
on 0430647081 or email stacy.leidel@student.curtin.edu.au. 
I know that I can contact the Research Ethics Officer at Curtin University on (08)9266 2784 
if I wish to discuss any aspects of the program on a confidential basis. 
I agree to participate in this project.  I have been assured that my identity will not be revealed 
while the program is being conducted or when the program is published.  
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Participant’s Name  Participant’s Signature  
    
Researcher’s Name  Researcher’s Signature  
Date    
Please keep a copy of this form for your records. 
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Appendix 4 Copyright license for the qualitative study (Leidel et al., 2015, 
Australasian Medical Journal) 
The AMJ grants to you a worldwide non-exclusive royalty-free revocable license to: 
● View this website and the material on this website on a computer or mobile device via a 
web browser; 
● Copy and store this website and the material on this website in your web browser cache 
memory; and 
● Print pages from this website for your own personal and non-commercial use. 
The AMJ does not grant you any other rights in relation to this website or the material on this 
website.  In other words, all other rights are reserved. 
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, 
republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website 
or the material on this website (in any form or media) without AMJ’s prior written permission. 
Data mining 
The automated and/or systematic collection of data from this website is prohibited. 
Permissions 
You may request permission to use the copyright materials on this website by writing to 
editor@amj.net.au or 115 King Street West, Suite 220 Dundas, On L9H 1V1, Canada. 
Enforcement of copyright 
The AMJ takes the protection of its copyright very seriously. 
If the AMJ discovers that you have used its copyright materials in contravention of 
the license above, AMJ may bring legal proceedings against you seeking monetary damages 
and an injunction to stop you using those materials.  You could also be ordered to pay legal 
costs. 
If you become aware of any use of AMJ’s copyright materials that contravenes or 
may contravene the license above, please report this by email to editor@amj.net.au or by post 
to 115 King Street West, Suite 220 Dundas, On L9H 1V1, Canada. 
Infringing material 
If you become aware of any material on the website that you believe infringes your or any 
other person’s copyright, please report this by email to editor@amj.net.au or by post to 115 
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King Street West, Suite 220 Dundas, On L9H 1V1, Canada. 
This copyright notice is based on an original template created by template-
contracts.co.uk and distributed by freenetlaw.com 
Authors who publish with this journal agree to the following terms: 
● 1. Authors grant the AMJ exclusive copyright. 
● 2. Authors are able to enter into separate, additional contractual arrangements for the non-
exclusive distribution of the journal’s published version of the work (e.g., post it to an 
institutional repository or publish it in a book), with an acknowledgement of its initial 
publication in this journal. 
● 3. Authors are permitted and encouraged to post their work online (e.g., in institutional 
repositories or on their website) prior to and during the submission process, as it can lead 
to productive exchanges, as well as earlier and greater citation of published work (See 
The Effect of Open Access). 
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Appendix 5 Copyright permission for Leidel et al., 2015, AIDS Care 
Our Ref: KB/CAIC/P9293 
5th December 2016 
Dear Stacy Leidel 
Thank you for your correspondence requesting permission to reproduce the following article 
published in our journal in your printed thesis and to be posted in your university’s 
repository. 
Health-care providers’ experiences with opt-out HIV testing: a systematic review – vol 27 no 
12 2015 pp 1455-1467 
We will be pleased to grant permission on the sole condition that you acknowledge the 
original source of publication and insert a reference to the article on the Journals 
website:http://www.tandfonline.com 
This is the authors accepted manuscript of an article published as the version of record in 
Aids Care, 2015 
http://www.tandfonline.com/doi/full/10.1080/09540121.2015.1058895 
Please note that this license does not allow you to post our content on any third party 
websites or repositories. 




Taylor & Francis Group 
Taylor & Francis Group is a trading name of Informa UK Limited, registered in England 
under no.  1072954 
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Appendix 8 Ethics approval for mixed-methods study (Leidel et al., 2017, Australian 








Appendix 10 Linkage to care protocol for mixed-methods study 
Opt-out HIV testing program at Homeless Healthcare: Linkage to care background and 
protocol 
This research project involves a trial of opt-out HIV testing in a general practice.  
Unlike traditional HIV testing (which is based on a patient’s request, risk factors, or clinical 
indications), opt-out testing is performed unless the patient declines the test.  This normalises 
and de-stigmatises HIV testing by putting it on par with other treatable, chronic diseases.  
Prompt diagnosis of the infection is important because early HIV treatment has been shown 
to stop immune dysfunction, and people with HIV who engage with care can now live a 
normal or near-normal life span.  To our knowledge, opt-out HIV testing in Australian GP 
practices has not yet been formally evaluated. 
In this project, we will implement opt-out HIV testing at Homeless Healthcare, a 
primary care service for homeless and marginalised people.  Our aims are 1) to explore the 
effect of the opt-out approach on testing rates and 2) to explore the acceptability and 
feasibility of opt-out HIV testing from the health care providers’ point of view.  The research 
will commence in April 2015 and is expected to continue for 12 months. 
Although the overall prevalence of HIV in Australia is low, there is a chance that a 
patient could test positive for HIV during the study period.  If this occurs, we will follow this 
protocol which has been developed by a multidisciplinary, collaborative team that includes 
Homeless Healthcare staff and HIV specialists.  If an HIV-positive result occurs, Homeless 
Healthcare staff will immediately contact the Nurse Practitioner and Social Worker from the 
hospital HIV Medicine service, who are experienced in discussing HIV-positive results with 
patients.  Homeless Healthcare staff will attempt to contact the patient within 24 hours after 
receipt of results from the laboratory.  The patient will be asked to present to the Homeless 
Healthcare main office or to a drop-in clinic.  Upon arrival to Homeless Healthcare, the 
patient will be escorted to the HIV Medicine service by a Homeless Healthcare RN.  The 
HIV Nurse Practitioner and/or Social Worker will then discuss the test results and treatment 
plan with the patient.  Alternatively, the Nurse Practitioner and/or Social Worker will come to 
the Homeless Healthcare drop-in clinic to meet with the patient, nurse and GP.  This referral 
pathway provides disclosure of HIV-positive results in a caring and confidential way, 




This research has been granted ethics approval (#4877) from the Curtin University 
Human Research Ethics Committee. 
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